Annual Statements Open main menu

ATLANTIC AMERICAN CORP - Annual Report: 2020 (Form 10-K)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-3722

ATLANTIC AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)

Georgia
 
58-1027114
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
4370 Peachtree Road, N.E.,
Atlanta, Georgia
 
30319
(Address of principal executive offices)
 
(Zip Code)

(Registrant’s telephone number, including area code) (404) 266-5500
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $1.00 per share
AAME
NASDAQ Global Market

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☐
Smaller reporting company ☒
Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The aggregate market value of common stock held by non-affiliates of the registrant as of June 30, 2020, the last business day of the registrant’s most recently completed second fiscal quarter, was $6,720,805. For purposes hereof, beneficial ownership is determined under rules adopted pursuant to Section 13 of the Securities Exchange Act of 1934, and the foregoing excludes value ascribed to common stock that may be deemed beneficially owned by the directors and executive officers, and 10% or greater stockholders, of the registrant, some of whom may not be deemed to be affiliates upon judicial determination. On March 10, 2021 there were 20,415,243 shares of the registrant’s common stock, par value $1.00 per share, outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s Proxy Statement for the 2021 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year end, have been incorporated by reference in Items 10, 11, 12, 13 and 14 of Part III of this Form 10-K.



TABLE OF CONTENTS

   
Page
PART I
   
Item 1.
1
 
1
 
2
 
3
 
3
 
4
 
5
 
6
 
6
 
7
 
7
  7
 
8
 
8
 
9
 
9
 
9
  9
 
10
Item 1A.
10
Item 1B.
10
Item 2.
10
Item 3.
11
Item 4.
11
     
PART II
   
Item 5.
12
Item 6.
12
Item 7.
13
Item 7A.
21
Item 8.
22
Item 9.
53
Item 9A.
53
Item 9B.
53
     
PART III
   
Item 10.
54
Item 11.
54
Item 12.
54
Item 13.
54
Item 14.
54
     
PART IV
   
Item 15.
55
Item 16.
56


PART I

Item 1.
Business

The Company

Atlantic American Corporation, a Georgia corporation incorporated in 1968 (the “Parent” or “Company”), is a holding company that operates through its subsidiaries in well-defined specialty markets within the life and health and property and casualty insurance industries. The Parent’s principal operating subsidiaries are American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance Company (together known as “Bankers Fidelity”) within the life and health insurance industry. Each of American Southern and Bankers Fidelity is managed separately based upon the type of products it offers, and is evaluated on its individual performance. The Company’s strategy is to focus on well-defined geographic, demographic and/or product niches within the insurance marketplace. Each of American Southern and Bankers Fidelity operates with relative autonomy, which structure is designed to allow for quick reaction to market opportunities.

The Parent has no significant business operations of its own and relies on fees, dividends and other distributions from its operating subsidiaries as the principal source of cash flow to meet its obligations. Additional information regarding the cash flow and liquidity needs of the Parent can be found in the Liquidity and Capital Resources section of Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Property and Casualty Operations

American Southern comprises the Company’s property and casualty operations and its primary product lines are as follows:

Business Automobile Insurance policies provide bodily injury and/or property damage liability coverage, uninsured motorist coverage and physical damage coverage for commercial accounts.

General Liability Insurance policies cover bodily injury and property damage liability for both premises and completed operations exposures for general classes of business.

Surety Bonds are contracts under which one party, the insurance company issuing the surety bond, guarantees to a third party that the primary party will fulfill an obligation in accordance with a contractual agreement. This obligation may involve meeting a contractual commitment, paying a debt or performing certain duties.

American Southern provides tailored business automobile insurance coverage, on a multi-year contract basis, to state governments, local municipalities and other large motor pools and fleets (“block accounts”) that can be specifically rated and underwritten. The size of the block accounts insured by American Southern are generally such that individual class experience can be determined, which allows for customized policy terms and rates. American Southern is licensed to do business in 32 states and the District of Columbia. While the majority of American Southern’s premiums are derived from its automobile lines of business, American Southern also offers inland marine and general liability coverages. Additionally, American Southern directly provides surety bond coverage for subdivision construction, as well as performance and payment bonds.

The following table summarizes, for the periods indicated, the allocation of American Southern’s net earned premiums from each of its principal product lines:

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(In thousands)
 
Automobile liability
 
$
30,312
   
$
30,649
 
Automobile physical damage
   
18,730
     
15,309
 
General liability
   
3,891
     
3,309
 
Surety
   
5,857
     
6,319
 
Other lines
   
3,582
     
3,094
 
Total
 
$
62,372
   
$
58,680
 

Life and Health Operations

Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary and term life insurance, Medicare supplement and other accident and health insurance products.

Life Insurance products include non-participating term, individual and group whole life insurance policies with a variety of riders and options. Policy premiums are dependent upon a number of factors, including issue age, level of coverage and selected riders or options.

Medicare Supplement Insurance includes 8 of the 10 standardized Medicare supplement policies created under the Medicare Improvements for Patients and Providers Act of 2008 (“MIPPA”), which are designed to provide insurance coverage for certain expenses not covered by the Medicare program, including copayments and deductibles.

Other Accident and Health Insurance coverages include several individual and group policies providing for the payment of standard benefits in connection with the treatment of diagnosed cancer and other critical illnesses, as well as a number of other policies providing short-term nursing facility care, accident expense, hospital indemnity and disability coverages.

Health insurance products, primarily Medicare supplement insurance, accounted for 92% of Bankers Fidelity’s net earned premiums in 2020 while life insurance, including both whole and term life insurance policies, accounted for the balance. In terms of the number of policies written in 2020, 83% were health insurance policies and 17% were life insurance policies.

The following table summarizes, for the periods indicated, the allocation of Bankers Fidelity’s net earned premiums from each of its principal product lines followed by a brief description of the principal products:

 
Year Ended December 31,
 
 
2020
   
2019
 
 
(In thousands)
 
Life insurance
 
$
9,270
   
$
8,427
 
Medicare supplement
   
102,680
     
107,001
 
Other accident and health
   
9,217
     
7,817
 
Total health insurance
   
111,897
     
114,818
 
Total
 
$
121,167
   
$
123,245
 

Marketing

Property and Casualty Operations

A portion of American Southern’s business is marketed through a small number of specialized, experienced independent agents. American Southern’s agent selection process is actively managed by internal marketing personnel with oversight from management. Senior management carefully reviews all new programs prior to acceptance. Most of American Southern’s agents are paid an up-front commission with the potential for additional commissions by participating in a profit sharing arrangement that is directly linked to the profitability of the underlying business. American Southern also solicits business from governmental entities. As an experienced writer of insurance policies for certain governmental programs, the company actively pursues this market on a direct basis. Much of this business is priced by means of competitive bid situations. As a result, there can be no assurance with respect to the ultimate profitability or ability of the Company to obtain or retain such business at the time of a specific contract renewal.

Life and Health Operations

Bankers Fidelity acquires its clientele through three distribution channels spread across 46 different states and two business divisions, all of which utilize commissioned, independent agents. The three distribution channels include traditional independent agents, brokers typically interested in a specific product of Bankers Fidelity and brokers who focus on sales within the group/employer benefits arena of BankersWorksite, all of which are responsible for their own marketing and sales activities. Contracting as independent agents enables Bankers Fidelity to effectively expand or contract its sales force without incurring significant expense.

Bankers Fidelity had 4,198 licensed agents contracted in both senior market and worksite divisions as of December 31, 2020. During 2020, approximately 786 of these licensed agents wrote policies on behalf of Bankers Fidelity.

Bankers Fidelity’s marketing and distribution strategy revolves around five pillars: Diversification, Differentiation, Quality, Retention and Profitability.

Diversification. Through unique product offerings such as the Vantage Recovery®, short-term care product and a group whole life product featuring a chronic illness rider, the Company is able to offer its distributors an array of products to sell that stand out from the competition. As the Company continues to expand its geographical footprint with agents and products, one of its main objectives is to have a healthy mix of all of its product lines nationwide.

Differentiation. Bankers Fidelity prides itself on the quality of customer service it offers to policyholders and agents. A dedicated agent support team is available to the field to support them on administration, underwriting, sales training, product questions and a plethora of other services which differentiates the Company from other carriers. Additionally, a customer loyalty team is available solely to serve insureds for any of their insurance needs. Bankers Fidelity prides itself on being agile, which we believe differentiates us from larger carriers and helps the Company to quickly execute senior management’s initiatives.

Quality. Bankers Fidelity is focused on being a niche carrier that delivers superior service, quality products and innovative solutions. Sophisticated technology and reporting allows the home office teams to work with the sales force to deliver a tailored experience and phenomenal customer service.

Retention. Through seasonal campaigns and customer outreach, the Company is focused on client retention and servicing its policyholders through all stages in their lives. By providing its agents with an innovative product portfolio, the Company further promotes client retention by empowering its agents to continually meet the needs of our policyholders.

Profitability. In an effort to be sustainable in the marketplace as a long-term partner, senior management is focused on diversification, differentiation, quality and retention to achieve profitability.

Underwriting

Property and Casualty Operations

American Southern specializes in underwriting various risks that are sufficiently large enough to establish separate class experience, relying upon the underwriting expertise of its agents.

During the course of the policy life, extensive use is made of risk management representatives to assist commercial underwriters in identifying and correcting potential loss exposures and to physically inspect new accounts. The underwriting results from each insured are reviewed on an individual basis periodically. If results are below expectations, management takes corrective action, which may include adjusting rates, revising underwriting standards, adjusting commissions paid to agents, and/or altering or declining to renew accounts at expiration.

Life and Health Operations

Bankers Fidelity issues a variety of products that span from the worksite markets to the senior markets for both life and health insurance. Products offered by Bankers Fidelity include life insurance, typically with small face amounts, Medicare supplement and other accident and health insurance. Bankers Fidelity also provides an array of worksite products such as accident, cancer, critical illness, hospital indemnity and life insurance that is offered to employers who are looking to provide coverage for their employees and have the related premiums deducted through payroll deductions.

The majority of the products are underwritten on a non-medical basis using a simplified issue approach by which an application containing a variety of health related questions is submitted. Applications for insurance are reviewed to determine the face amount, age, medical history and any other necessary information. Bankers Fidelity utilizes information obtained directly from the insured, the medical claims data, prescription utilization reports as well as telephone interviews to determine whether an applicant meets the Company’s underwriting criteria. Bankers Fidelity may also utilize medical records and investigative services to supplement and substantiate information, as necessary.

Policyholder and Claims Services

The Company believes that prompt, efficient policyholder and claims services are essential to its continued success in marketing its insurance products (see “Competition”). Additionally, the Company believes that its insureds are particularly sensitive to claims processing time and to the accessibility of qualified staff to answer inquiries. Accordingly, the Company’s policyholder and claims services seek to offer expeditious disposition of service requests by providing toll-free access for all customers, 24-hour claim reporting services, and direct computer links with some of its largest accounts. The Company also utilizes an automatic call distribution system to ensure that inbound calls to customer service support groups are processed efficiently. Operational data generated from this system allows management to further refine ongoing client service programs and service representative training modules.

Property and Casualty Operations

American Southern controls its claims costs by utilizing an in-house staff of claims supervisors to investigate, verify, negotiate and settle claims. Upon notification of an occurrence purportedly giving rise to a claim, a claim file is established. The claims department then conducts a preliminary investigation, determines whether an insurable event has occurred and, if so, updates the file for the findings and any required reserve adjustments. Independent adjusters and appraisers are frequently utilized to service claims which require on-site inspections.

Life and Health Operations

Insureds may obtain claim forms by calling the claims department customer service group or through Bankers Fidelity’s website. Insureds covered under a group policy may also file a claim directly on the Company’s website. To shorten claim processing time, a letter detailing all supporting documents that are required to complete a claim for a particular policy is sent to the customer along with the correct claim form. With respect to life policies, the claim is entered into Bankers Fidelity’s claims system when the proper documentation is received. Properly documented claims are generally paid within five business days of receipt. With regard to Medicare supplement policies, the claim is either directly billed to Bankers Fidelity by the provider or sent electronically through a Medicare clearing house.

Reserves

Reserves are set by line of business within each of the subsidiaries. At December 31, 2020, approximately 69% of the losses and claims reserves related to property and casualty and approximately 31% related to life and health. The Company’s property and casualty operations incur losses which may take extended periods of time to evaluate and settle. Issues with respect to legal liability, actual loss quantification, legal discovery and ultimate subrogation, among other factors, may influence the initial and subsequent estimates of loss. In the property and casualty operations, the Company’s general practice is to reserve at the higher end of the determined reasonable range of loss if no other value within the range is determined to be more probable. The Company’s life and health operations generally incur losses which are more readily quantified. Medical claims received are recorded in case reserves based on contractual terms using the submitted billings as a basis for determination. Life claims are recorded based on contract value at the time of notification to the Company; offset by policy reserves related to such contracts previously established. Individual case reserves are established by a claims processor on each individual claim and are periodically reviewed and adjusted as new information becomes known during the course of handling a claim. Regular internal periodic reviews are also performed by management to ensure that loss reserves are established and revised timely relative to the receipt of new or additional information. Lines of business for which loss data (e.g. paid losses and case reserves) emerge over a long period of time are referred to as long-tail lines of business. Lines of business for which loss data emerge more quickly are referred to as short-tail lines of business. The Company’s long-tail line of business generally consists of its general liability coverage while the short-tail lines of business generally consist of property and automobile coverages.

The Company’s actuaries regularly review reserves for both current and prior accident years using the most current claims data. These reviews incorporate a variety of actuarial methods (discussed in Critical Accounting Policies) and judgments and involve a disciplined analysis. For most lines of business, certain actuarial methods and specific assumptions are deemed more appropriate based on the current circumstances affecting that line of business. These selections incorporate input from claims personnel and operating management on reported loss cost trends and other factors that could affect the reserve estimates.

For long-tail lines of business, the emergence of paid losses and case reserves is less credible in the early periods, and accordingly may not be indicative of ultimate losses. For these lines, methods which incorporate a development pattern assumption are given less weight in calculating incurred but not reported (“IBNR”) reserves for the early periods of loss emergence because such a low percentage of ultimate losses are reported in that time frame. Accordingly, for any given accident year, the rate at which losses on long-tail lines of business emerge in the early periods is generally not as reliable an indication of ultimate losses as it would be for shorter-tail lines of business. The estimation of reserves for these lines of business in the early periods of loss emergence is therefore largely influenced by statistical analyses and application of prior accident years’ loss ratios, after considering changes to earned pricing, loss costs, mix of business, ceded reinsurance and other factors that are expected to affect the estimated ultimate losses. For later periods of loss emergence, methods which incorporate a development pattern assumption are given more weight in estimating ultimate losses. For short-tail lines of business, the emergence of paid loss and case reserves is more credible in the early periods and is more likely to be indicative of ultimate losses. The method used to set reserves for these lines of business is based upon utilization of a historical development pattern for reported losses. IBNR reserves for the current year are set as the difference between the estimated fully developed ultimate losses for each year, less the established, related case reserves and cumulative related payments. IBNR reserves for prior accident years are similarly determined, again relying on an indicated, historical development pattern for reported losses.

Based on the results of regular reserve estimate reviews, the Company determines the appropriate reserve adjustment, if any, to record in each period. If necessary, recorded reserve estimates are changed after consideration of numerous factors, including, but not limited to, the magnitude of the difference between the actuarial indication and the recorded reserves, improvement or deterioration of actuarial indication in the period, the maturity of the accident year, trends observed over the recent past and the level of volatility within a particular line of business. In general, changes are made more quickly to recognize changes in estimates to ultimate losses in mature accident years and less volatile lines of business.

Estimating case reserves and ultimate losses involves various considerations which differ according to the line of business. In addition, changes in legislative and regulatory environments may impact loss estimates. General liability claims may have a long pattern of loss emergence. Given the broad nature of potential general liability coverages, investigative time periods may be extended and questions of coverage may exist. Such uncertainties create greater imprecision in estimating required levels of loss reserves. The property and automobile lines of business generally have less variable reserve estimates than other lines. This is largely due to the coverages having relatively shorter periods of loss emergence. Estimates, however, can still vary due to a number of factors, including interpretations of frequency and severity trends. Severity trends can be impacted by changes in internal claim handling and reserving practices in addition to changes in the external environment. These changes in claim practices increase the uncertainty in the interpretation of case reserve data, which increases the uncertainty in recorded reserve levels.

The Company’s policy is to record reserves for losses and claims in amounts which approximate actuarial best estimates of ultimate values. Actuarial best estimates do not necessarily represent the midpoint value determined using the various actuarial methods; however, such estimates will fall between the estimated low and high end reserve values. The range of estimates developed in connection with the December 31, 2020 actuarial review indicated that reserves could be as much as 10.9% lower or as much as 2.0% higher. In the opinion of management, recorded reserves represent the best estimate of outstanding losses, although significant judgments are made in the derivation of reserve estimates and revisions to such estimates are expected to be made in future periods. Any such revisions could be material, and may materially adversely affect the Company’s financial condition and results of operations in any future period.

Property and Casualty Operations

American Southern maintains loss reserves representing estimates of amounts necessary for payment of losses and loss adjustment expense (“LAE”), and which are not discounted. IBNR reserves are also maintained for future development. These loss reserves are estimates, based on known facts and circumstances at a given date, of amounts the Company expects to pay on incurred claims. All balances are reviewed periodically by the Company’s independent consulting actuary. Reserves for LAE are intended to cover the ultimate costs of settling claims, including investigation and defense of any lawsuits resulting from such claims. Loss reserves for reported claims are based on a case-by-case evaluation of the type of claim involved, the circumstances surrounding the claim, and the policy provisions relating to the type of loss along with anticipated future development. The LAE for claims reported and claims not reported is based on historical statistical data and anticipated future development. Inflation and other factors which may affect claim payments are implicitly reflected in the reserving process through analysis and consideration of cost trends and reviews of historical reserve results.

American Southern establishes reserves for claims based upon: (a) management’s estimate of ultimate liability and claims adjusters’ evaluations of unpaid claims reported prior to the close of the accounting period, (b) estimates of IBNR claims based on past experience, and (c) estimates of LAE. If no value is determined to be more probable in estimating a loss after considering all factors, the Company’s general practice is to reserve at the higher end of the determined reasonable range of loss. The estimated liability is periodically reviewed and updated, and changes to the estimated liability are recorded in the statement of operations in the period in which such changes become known.

Life and Health Operations

Bankers Fidelity establishes liabilities for future policy benefits to meet projected future obligations under outstanding policies. These reserves are calculated to satisfy policy and contract obligations as they mature. The amount of reserves for insurance policies is calculated using assumptions for interest rates, mortality and morbidity rates, expenses, and withdrawals. Reserves are adjusted periodically based on published actuarial tables with modifications to reflect actual experience. The use of significantly different assumptions, or actual results that differ significantly from our estimates, could materially adversely affect our liquidity, results of operations or financial condition.

See Note 5 of Notes to Consolidated Financial Statements for more information on insurance reserves and policyholder funds.

Reinsurance

The Company’s insurance subsidiaries from time to time purchase reinsurance from unaffiliated insurers and reinsurers to reduce their potential liability on individual risks and to protect against catastrophic losses. In a reinsurance transaction, an insurance company transfers, or “cedes,” a portion or all of its exposure on insurance policies to a reinsurer. The reinsurer assumes the exposure in return for a portion of the premiums. The ceding of insurance does not legally discharge the insurer from primary liability for the full amount of the policies written by it, and the ceding company will incur a loss if the reinsurer fails to meet its obligations under the reinsurance agreement.

Property and Casualty Operations

American Southern’s basic reinsurance treaties generally cover all claims in excess of specified per occurrence limitations. Limits per occurrence within the reinsurance treaties are as follows: Inland marine and commercial automobile physical damage - $250,000 excess of $100,000 retention; and automobile liability and general liability - excess coverage of $2.0 million less retentions that may vary from $100,000 to $300,000 depending on the account. American Southern maintains a property catastrophe treaty with a $5.7 million limit excess of $300,000 retention. American Southern also issues individual surety bonds with face amounts generally up to $1.5 million, and limited to $5.0 million in aggregate per account, that are not reinsured.

Life and Health Operations

Bankers Fidelity has entered into reinsurance contracts ceding the excess of its life retention. Maximum retention by Bankers Fidelity on any one individual in the case of life insurance policies is $100,000. At December 31, 2020, $11.0 million of the $294.4 million of life insurance in force at Bankers Fidelity was reinsured under a mix of coinsurance and yearly renewable term agreements. Certain prior year reinsurance agreements also remain in force although they no longer provide reinsurance for new business.

Bankers Fidelity has also entered into a reinsurance contract ceding excess new Medicare supplement business to General Re Life Corporation. Ceding thresholds are set annually. During 2020, the liability of the reinsurer was 50% of all new Medicare supplement business issued by the Company on amounts up to a maximum retention of $15.0 million of annualized premium. Accordingly, $3.3 million of the Company’s $6.7 million of new annualized Medicare supplement premium was ceded.

Competition

Competition for insurance products is based on many factors including premiums charged, terms and conditions of coverage, customer service, financial ratings assigned by independent rating agencies, claims handling, consumer recognition and reputation, perceived financial strength and the experience of the organization in the line of business being written.

Property and Casualty Operations

The businesses in which American Southern engages are highly competitive. The principal areas of competition are pricing and service. Many competing property and casualty companies have been in business longer than American Southern, offer more diversified lines of insurance and have substantially greater financial resources. Management believes, however, that the policies it sells are competitive with those providing similar benefits offered by other insurers doing business in the states in which American Southern operates. American Southern strives to develop strong relationships with its agents and, consequently, believes it is well positioned for new opportunities and programs with those agents.

Life and Health Operations

The life and health insurance business remains highly competitive and includes a large number of insurance companies, many of which are new entrants to the business of providing Medicare supplement and other accident and health insurance products. Bankers Fidelity has established itself as a trusted carrier of choice for its customers providing quality and sustainability for nearly 65 years.

In order to compete, Bankers Fidelity actively seeks opportunities in niche markets, developing long-term relationships with a select number of independent marketing organizations. Additionally, Bankers Fidelity actively promotes BankersWorksite, the group benefits division, as well as selective association partnerships. It competes with other insurers to attract and retain the allegiance of its independent agents through commission and sales incentive arrangements, accessibility and marketing assistance, lead programs, reputation and market expertise. Bankers Fidelity successfully competes in its chosen markets by establishing relationships with independent agents and providing proprietary marketing initiatives as well as providing outstanding service to policyholders.

Ratings

Ratings are important measures within the insurance industry, and higher ratings are expected to have a favorable impact on the ability of a company to compete in the marketplace. Ratings of insurance companies are not designed for investors and do not constitute recommendations to buy, sell, or hold any security.

Each year A.M. Best Company, Inc. (“A.M. Best”) publishes Best’s Insurance Reports, which includes assessments and ratings of all insurance companies. A.M. Best’s financial strength ratings, which may be revised or revoked at any time, follow a graduated scale of rating categories and notches ranging from A++ (Superior) to F (in liquidation). A.M. Best’s ratings are based on a detailed analysis of the statutory financial condition and operations of an insurance company compared to the industry in general.

American Southern. American Southern Insurance Company and its wholly-owned subsidiary, American Safety Insurance Company, are each, as of the date of this report, rated “A” (Excellent) by A.M. Best.

Bankers Fidelity. Bankers Fidelity Life Insurance Company and its wholly-owned subsidiary, Bankers Fidelity Assurance Company, are each, as of the date of this report, rated “A-” (Excellent) by A.M. Best.

Regulation

Like all domestic insurance companies, the Company’s insurance subsidiaries are subject to regulation and supervision in the jurisdictions in which they do business. Statutes typically delegate regulatory, supervisory, and administrative powers to state insurance commissioners. The method of such regulation varies, but regulation relates generally to the licensing of insurers and their agents, the nature of and limitations on investments, approval of policy forms, reserve requirements, the standards of solvency to be met and maintained, deposits of securities for the benefit of policyholders, and periodic examinations of insurers and trade practices, among other things. The Company’s products generally are subject to rate regulation by state insurance commissions, which require that certain minimum loss ratios be maintained. Certain states also have insurance holding company laws which require registration and periodic reporting by insurance companies controlled by other corporations licensed to transact business within their respective jurisdictions. The Company’s insurance subsidiaries are subject to such legislation and are registered as controlled insurers in those jurisdictions in which such registration is required. Such laws vary from state to state, but typically require periodic disclosure concerning the corporation which controls the registered insurers and all subsidiaries of such corporations, as well as prior notice to, or approval by, the state insurance commissioners of intercorporate transfers of assets (including payments of dividends by the insurance subsidiaries in excess of specified amounts) within the holding company system. The Company believes it is in compliance with all such requirements.

Most states require that rate schedules and other information be filed with the state’s insurance regulatory authority, either directly or through a ratings organization with which the insurer is affiliated. The regulatory authority may disapprove a rate filing if it determines that the rates are inadequate, excessive, or discriminatory. The Company has historically experienced no significant regulatory resistance to its applications for rate adjustments; however, the Company cannot provide any assurance that it will not receive any objections to any applications in the future.

A state may require that acceptable securities be deposited for the protection either of policyholders located in those states or of all policyholders. As of December 31, 2020, the Company was in compliance with all such requirements, and securities with an amortized cost of $10.7 million were on deposit either directly with various state authorities or with third parties pursuant to various custodial agreements on behalf of the Company’s insurance subsidiaries.

Virtually all of the states in which the Company’s insurance subsidiaries are licensed to transact business require participation in their respective guaranty funds designed to cover claims against insolvent insurers. Insurers authorized to transact business in these jurisdictions are generally subject to assessments of up to 4% of annual direct premiums written in that jurisdiction to pay such claims, if any. The likelihood and amount of any future assessments cannot be estimated until an insolvency has occurred.

NAIC Ratios

The National Association of Insurance Commissioners (the “NAIC”) was established to, among other things, provide guidelines to assess the financial strength of insurance companies for state regulatory purposes. The NAIC conducts annual reviews of the financial data of insurance companies primarily through the application of financial ratios prepared on a statutory basis. Annual statements are required to be submitted to state insurance departments to assist them in monitoring insurance companies in their state and to allow such states to determine a desirable range for each such ratio with which companies should comply.

The NAIC developed the Insurance Regulatory Information System (“IRIS”) to help state regulators identify companies that may require regulatory attention. Financial examiners review annual financial statements and the results of key financial ratios based on year-end data with the goal of identifying insurers that appear to require immediate regulatory attention. Each ratio has an established “usual range” of results. A ratio result falling outside the usual range, however, is not necessarily considered adverse; rather, unusual values are used as part of the regulatory early monitoring system. Furthermore, in some years, it may not be unusual for financially sound companies to have several ratios with results outside the usual ranges. Generally, an insurance company may become subject to regulatory scrutiny or, depending on the company’s financial condition, regulatory action if certain of its key IRIS ratios fall outside the usual ranges and the insurer’s financial condition is trending downward.

For the year ended December 31, 2020, Bankers Fidelity Life Insurance Company had no IRIS ratios outside the usual ranges. However, Bankers Fidelity Assurance Company had three ratios outside the usual range primarily as a result of net loss for the year, certain surplus ratios and nonadmitted assets to admitted assets. The net loss at Bankers Fidelity Assurance Company is primarily related to federal income taxes incurred which resulted in a corresponding decrease in surplus levels for the year as well as a growing deferred tax asset which is reduced by admissibility limitations. American Southern Insurance Company and American Safety Insurance Company had no IRIS ratios outside the usual ranges. Management does not anticipate regulatory action as a result of the 2020 IRIS ratio results for the insurance subsidiaries.

Risk-Based Capital

Risk-based capital (“RBC”) is a metric used by ratings agencies and regulators as an early warning tool to identify weakly capitalized companies for the purpose of initiating further regulatory action. The RBC calculation determines the amount of adjusted capital needed by a company to avoid regulatory action. “Authorized Control Level Risk-Based Capital” (“ACL”) is calculated, and if a company’s adjusted capital is 200% or lower than ACL, it is subject to regulatory action. At December 31, 2020, the Company’s insurance subsidiaries’ RBC levels exceeded the required regulatory levels.

Information Technology and Cybersecurity

The Company’s operations rely on the secure processing, storage, and transmission of confidential and personal identifiable information within technology platforms. Cybersecurity is a high priority and the Company has made significant investments in order to prevent, detect, and respond to cyber threats. In recent years, the Company has enhanced intrusion protection and detection technology, infrastructure and application firewalls, and network monitoring. The Company has also installed advanced endpoint threat protection technology and implemented a mandatory security awareness training program for all employees.

The Company has a sophisticated technology environment that supports the replication of data across multiple secure data centers. It also includes a comprehensive disaster recovery plan that is continually tested to ensure capabilities to resume business in the event of a disaster. The Company’s technology environment is managed by an experienced team of professionals who follow an extensive set of policies and procedures related to data security. Through recurring internal and external audits, controls are regularly reviewed, tested, and enhanced to ensure best practices. The Company has augmented the information security program through a partnership with a leading global cybersecurity provider to review and implement additional services such as Security Event Monitoring, Advanced Endpoint Threat Detection, Incident Management Retainer Services, and Strategic Advisory Services focused on Chief Information Security Officer (CISO) duties such as counter-threat intelligence.

The information security program also includes a cybersecurity Incident Response Plan (“IRP”) that was established to help protect the integrity, availability and confidentiality of information, prevent loss of service, and comply with legal requirements. The IRP specifies the process for identifying and reporting an incident, initial investigation, risk classification, documentation and communication of incidents, responder procedures, incident reporting, and ongoing training. Additionally, the IRP specifies the notification to directors, officers, and other corporate insiders to not trade the Company’s securities while in possession of potentially material nonpublic information about the incident.

The Audit Committee of the Board of Directors has oversight of the Company’s information security program. The Company’s senior officers, including its Chief Information Officer, are responsible for the operation of the information security program and regularly communicate with the Audit Committee on the state of the program.

The Company also maintains dedicated cyber liability insurance for breach event costs, including: post breach event remediation costs; cyber crime coverage (including financial fraud, telecommunications fraud, and phishing attacks); and coverage for system failure, bricking loss, and physical damage. The policy also provides coverage for lost revenue due to a damaged reputation from a cyber breach.

Investments

Investment income represents a significant portion of the Company’s operating and total income. Insurance company investments are subject to state insurance laws and regulations which limit the concentration and types of investments. The following table provides information on the Company’s investments as of the dates indicated.

   
December 31,
 
   
2020
   
2019
 
   
Amount
   
Percent
   
Amount
   
Percent
 
   
(Dollars in thousands)
 
Fixed maturities:
                       
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
30,762
     
11.0
%
 
$
20,259
     
7.5
%
States, municipalities and political subdivisions
   
11,802
     
4.2
     
11,940
     
4.5
 
Public utilities
   
13,651
     
4.9
     
11,449
     
4.3
 
All other corporate bonds
   
197,641
     
70.8
     
188,574
     
70.2
 
Redeemable preferred stock
   
250
     
0.1
     
250
     
0.1
 
Total fixed maturities(1)
   
254,106
     
91.0
     
232,472
     
86.6
 
Common and non-redeemable preferred stocks(2)
   
18,716
     
6.7
     
22,922
     
8.5
 
Policy loans(3)
   
1,975
     
0.7
     
2,007
     
0.7
 
Other invested assets(4)
   
3,238
     
1.2
     
9,960
     
3.7
 
Real estate
   
38
     
0.0
     
38
     
0.0
 
Investments in unconsolidated trusts
   
1,238
     
0.4
     
1,238
     
0.5
 
Total investments
 
$
279,311
     
100.0
%
 
$
268,637
     
100.0
%

(1)
Fixed maturities are carried on the balance sheet at estimated fair value. Certain fixed maturities do not have publicly quoted prices, and are carried at estimated fair value as determined by management. Total amortized cost of fixed maturities was $222.5 million as of December 31, 2020 and $219.2 million as of December 31, 2019.
(2)
Equity securities are carried on the balance sheet at estimated fair value. Total cost of equity securities was $6.4 million as of December 31, 2020 and $7.2 million as of December 31, 2019.
(3)
Policy loans are valued at unpaid principal balances.
(4)
Other invested assets are accounted for using the equity method. Total cost of other invested assets was $3.8 million as of December 31, 2020 and $9.9 million as of December 31, 2019.

Estimated fair values are determined as discussed in Note 1 of Notes to Consolidated Financial Statements.

Results of the Company’s investment portfolio for periods shown were as follows:

 
Year Ended December 31,
 
 
2020
   
2019
 
 
(Dollars in thousands)
 
Average investments(1)
 
$
252,141
   
$
253,467
 
Net investment income
   
7,744
     
8,979
 
Average yield on investments
   
3.1
%
   
3.5
%
Realized investment gains, net
   
7,420
     
1,574
 

(1)
Calculated as the average of cash and investment balances (at amortized cost) at the beginning of the year and at the end of each of the succeeding four quarters.

During 2019, the Company engaged a global investment management firm serving the insurance industry to manage the Company’s investment portfolios. Management’s recent investment strategy has been a continued focus on quality and diversification, while improving the overall risk versus return profile of the portfolio.

Employees

The Company and its subsidiaries employed 153 people at December 31, 2020. Of the 153 people employed at December 31, 2020, 152 were full-time.

Financial Information by Industry Segment

Each of American Southern and Bankers Fidelity operate with relative autonomy and each company is evaluated on its individual performance. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each segment derives revenue from the collection of premiums, as well as from investment income. Substantially all revenue other than that in the corporate and other segment is from external sources. See Note 15 of Notes to Consolidated Financial Statements.

Available Information

The Company files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, amendments to those reports and other information with the Securities and Exchange Commission (the “SEC”). The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, including the Company. In addition, as soon as reasonably practicable after such materials are filed with or furnished to the SEC by the Company, the Company makes copies available to the public, free of charge, on or through its web site at www.atlam.com. Neither the Company’s website, nor the information appearing on the website, is included, incorporated into, or a part of, this report.

Executive Officers of the Registrant

The table and information below set forth, for each executive officer of the Company as of December 31, 2020, his name, age, positions with the Company and business experience for the past five years, as well as any prior service to the Company.

Name
 
Age
 
Positions with the Company
 
Director or Officer Since
Hilton H. Howell, Jr.
 
58
 
Chairman of the Board, President & CEO
 
1992
J. Ross Franklin
 
43
 
Vice President, CFO and Corporate Secretary
 
2017

Officers are elected annually and serve at the discretion of the board of directors.

Mr. Howell has been President and Chief Executive Officer of the Company since May 1995, and prior thereto served as Executive Vice President of the Company from October 1992 to May 1995. He has been a Director of the Company since October 1992 and effective February 24, 2009, began serving as Chairman of the board of directors. He is also Executive Chairman and Chief Executive Officer of Gray Television, Inc.

Mr. Franklin has been Vice President, Chief Financial Officer and Corporate Secretary of the Company since November 2017, and prior thereto served as Interim Chief Financial Officer from August 2017 to November 2017. Since 2000 he has held various roles of increasing responsibility with Atlantic American and its subsidiaries, previously serving as Vice President, Accounting and Treasurer of Bankers Fidelity since 2009.

Forward-Looking Statements

Certain of the statements contained or incorporated by reference herein are forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Exchange Act of 1933, and Section 21E of the Securities Act of 1934, and include estimates and assumptions related to, among other things, general economic, competitive, operational and legislative developments. Forward-looking statements are subject to changes and uncertainties which are, in many instances, beyond the Company’s control and have been made based upon management’s current expectations and beliefs concerning future developments and their potential effect upon the Company. There can be no assurance that future developments will be in accordance with management’s expectations or that the effect of future developments on the Company will be those anticipated by management. Actual results could differ materially from those expected by the Company, depending on the occurrence or outcome of various factors. These factors include, among others: significant changes in general economic conditions; unexpected developments in the health care or insurance industries affecting providers or individuals, including the cost or availability of services, or the tax consequences related thereto; disruption to the financial markets; unanticipated increases in the rate, number and amounts of claims outstanding; the level of performance of reinsurance companies under reinsurance contracts and the availability, pricing and adequacy of reinsurance to protect the Company against losses; changes in the stock markets, interest rates or other financial markets, including the potential effect on the Company’s statutory capital levels; the uncertain effect on the Company of regulatory and market-driven changes in practices relating to the payment of incentive compensation to brokers, agents and other producers; the impact of COVID-19 or other public health emergencies; the incidence and severity of catastrophes, both natural and man-made; the possible occurrence of terrorist attacks; stronger than anticipated competitive activity; unfavorable judicial or legislative developments; the potential effect of regulatory developments, including those which could increase the Company’s business costs and required capital levels; the Company’s ability to distribute its products through distribution channels, both current and future; the uncertain effect of emerging claim and coverage issues; the effect of assessments and other surcharges for guaranty funds and other mandatory pooling arrangements; and risks related to cybersecurity matters, such as breaches of our computer network or the loss of unauthorized access to the data we maintain. Many of such factors are beyond the Company’s ability to control or predict. As a result, the Company’s actual financial condition and results of operations could differ materially from those expressed in any forward-looking statements made by the Company. Undue reliance should not be placed upon forward-looking statements. The Company does not intend to publicly update any forward-looking statements that may be made from time to time by, or on behalf of, the Company.

Item 1A.
Risk Factors

As a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K (a “smaller reporting company”), we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

Item 1B.
Unresolved Staff Comments

Not applicable.

Item 2.
Properties

Leased Properties. The Company leases space for its principal offices and for some of its insurance operations in an office building located in Atlanta, Georgia, from Delta Life Insurance Company under a lease which continues until either party provides written notice of cancellation at least twelve months in advance of the actual termination date. The lease, which commenced on November 1, 2007, provides for rent adjustments on every fifth anniversary of the commencement date. Under the current terms of the lease, the Company occupies approximately 49,586 square feet of office space. Delta Life Insurance Company, the owner of the building, is controlled by an affiliate of the Company.

American Southern leases space for its office in a building located in Atlanta, Georgia. The lease term expires September 30, 2026. Under the terms of the lease, American Southern occupies approximately 17,014 square feet.

The Company believes that its current properties are in good condition, and are sufficient for the operations of its business.

Item 3.
Legal Proceedings

From time to time, the Company and its subsidiaries are, and expect to continue to be, involved in various claims and lawsuits arising in the ordinary course of business, both as a liability insurer defending third-party claims brought against insureds and as an insurer defending coverage claims brought against it. The Company accounts for such exposures through the establishment of loss and loss adjustment expense reserves. We do not expect that the ultimate liability, if any, with respect to such ordinary-course claims litigation, after consideration of provisions made for probable losses and costs of defense, will be material to the Company’s consolidated financial condition, although the results of such litigation could be material to the consolidated results of operations for any given period.

Item 4.
Mine Safety Disclosures

Not applicable.

PART II

Item 5.
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

The Company’s common stock is listed on the Nasdaq Global Market (Symbol: AAME). As of March 10, 2021, there were 6,428 shareholders of record.

On March 23, 2021, the Company’s board of directors declared an annual cash dividend of $0.02 per share of common stock that is payable to shareholders of record as of the close of business on April 13, 2021. Payment of any dividends in the future will be at the discretion of the Company’s board of directors and will depend upon the financial condition, capital requirements, and earnings of the Company, as well as any restrictions contained in any agreements by which the Company is bound and other factors as the board of directors may deem relevant. The Company’s primary recurring source of cash for the payment of dividends is dividends from its subsidiaries; although as of December 31, 2020, the Parent held unrestricted cash and investment balances of approximately $4.7 million. Under the insurance code of the state in which each insurance subsidiary is domiciled, dividend payments to the Company by its insurance subsidiaries are subject to certain limitations, including prior notice to, or approval by, the state insurance commissioners if such dividends are in excess of specified amounts.  In 2021, dividend payments to the Parent by the insurance subsidiaries in excess of $9.6 million would require prior approval.

Issuer Purchases of Equity Securities

On October 31, 2016, the Board of Directors of the Company approved a plan that allows for the repurchase of up to 750,000 shares of the Company’s common stock (the “Repurchase Plan”) on the open market or in privately negotiated transactions, as determined by an authorized officer of the Company. Any such repurchases can be made from time to time in accordance with applicable securities laws and other requirements.

Other than pursuant to the Repurchase Plan, no purchases of common stock of the Company were made by or on behalf of the Company during the periods described below.

The table below sets forth information regarding repurchases by the Company of shares of its common stock on a monthly basis during the three month period ended December 31, 2020.

Period
 
Total
Number
of Shares
Purchased
   
Average
Price Paid
per Share
   
Total
Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs
   
Maximum
Number of Shares
that May Yet be
Purchased Under the
Plans or Programs
 
October 1 – October 31, 2020
   
   
$
     
     
325,129
 
November 1 – November 30, 2020
   
     
     
     
325,129
 
December 1 – December 31, 2020
   
     
     
     
325,129
 
Total
   
   
$
     
         

Stock Performance Graph

As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

Item 6.
Selected Financial Data

As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following is management’s discussion and analysis of the financial condition and results of operations of Atlantic American Corporation (“Atlantic American” or the “Parent”) and its subsidiaries (collectively with the Parent, the “Company”) for the years ended December 31, 2020 and 2019. This discussion should be read in conjunction with the consolidated financial statements and notes thereto included elsewhere herein.

Atlantic American is an insurance holding company whose operations are conducted primarily through its insurance subsidiaries: American Southern Insurance Company and American Safety Insurance Company (together known as “American Southern”) in the property and casualty insurance industry, and Bankers Fidelity Life Insurance Company and Bankers Fidelity Assurance Company (together known as “Bankers Fidelity”) in the life and health insurance industry. Each operating company is managed separately, offers different products and is evaluated on its individual performance.

Critical Accounting Policies

The accounting and reporting policies of the Company are in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and, in management’s belief, conform to general practices within the insurance industry. The following is an explanation of the Company’s accounting policies and the resultant estimates considered most significant by management. These accounting policies inherently require significant judgment and assumptions and actual operating results could differ significantly from management’s estimates determined using these policies. Atlantic American does not expect that changes in the estimates determined using these policies will have a material effect on the Company’s financial condition or liquidity, although changes could have a material effect on its consolidated results of operations.

Cash and investments comprised 74% of the Company’s total assets at December 31, 2020. Substantially all of the Company’s investments are in bonds and common and preferred stocks, the values of which are subject to significant market fluctuations. The Company carries all fixed maturities, which includes bonds and redeemable preferred stocks, and equity securities, which includes common and non-redeemable preferred stocks, as available for sale and, accordingly, at their estimated fair values. On occasion, the value of a fixed maturity investment may decline to a value below its amortized purchase price and remain at such value for an extended period of time. When a fixed maturity investment’s indicated fair value has declined below its cost basis for a period of time, the Company evaluates such investment for an other than temporary impairment. The evaluation for an other than temporary impairment is a quantitative and qualitative process, which is subject to risks and uncertainties in the determination of whether declines in the fair value of investments are other than temporary. Potential risks and uncertainties include, among other things, changes in general economic conditions, an issuer’s financial condition or near term recovery prospects and the effects of changes in interest rates. In evaluating a potential impairment, the Company considers, among other factors, management’s intent and ability to hold the securities until price recovery, the nature of the investment and the expectation of prospects for the issuer and its industry, the status of an issuer’s continued satisfaction of its obligations in accordance with their contractual terms, and management’s expectation as to the issuer’s ability and intent to continue to do so, as well as ratings actions that may affect the issuer’s credit status. If an other than temporary impairment is deemed to exist, then the Company will write down the amortized cost basis of the investment to its estimated fair value. While any such write down does not impact the reported value of the investment in the Company’s balance sheet, it is reflected as a realized investment loss in the Company’s net income or other comprehensive income, depending upon the nature of the loss, in the period incurred.

The Company determines the fair values of certain financial instruments based on the fair value hierarchy established in Accounting Standards Codification (“ASC”) 820-10-20, Fair Value Measurements and Disclosures (“ASC 820-10-20”). The fair values of fixed maturities and equity securities are largely determined by nationally quoted market prices, when available, or independent broker quotations. See Note 2 and Note 3 of Notes to Consolidated Financial Statements with respect to assets and liabilities carried at fair value and information about the inputs used to value those financial instruments, by hierarchy level, in accordance with ASC 820-10-20.

Future policy benefits comprised 35% of the Company’s total liabilities at December 31, 2020. These liabilities relate primarily to life insurance products and are based upon assumed future investment yields, mortality rates, withdrawal rates and expenses after giving effect to possible risks of adverse deviation. The assumed mortality and withdrawal rates are based upon the Company’s experience modified as necessary to reflect anticipated trends and are generally established at contract inception. If actual results differ from the initial assumptions, the amount of the Company’s recorded liability could require adjustment.

Unpaid loss and loss adjustment expenses comprised 30% of the Company’s total liabilities at December 31, 2020. This liability includes estimates for: 1) unpaid losses on claims reported prior to December 31, 2020, 2) future development on those reported claims, 3) unpaid ultimate losses on claims incurred prior to December 31, 2020 but not yet reported and 4) unpaid loss adjustment expenses for reported and unreported claims incurred prior to December 31, 2020. Quantification of loss estimates for each of these components involves a significant degree of judgment and estimates may vary, materially, from period to period. Estimated unpaid losses on reported claims are developed based on historical experience with similar claims by the Company. Development on reported claims, estimates of unpaid ultimate losses on claims incurred prior to December 31, 2020 but not yet reported, and estimates of unpaid loss adjustment expenses are developed based on the Company’s historical experience, using actuarial methods to assist in the analysis. The Company’s actuaries develop ranges of estimated development on reported and unreported claims as well as loss adjustment expenses using various methods, including the paid-loss development method, the reported-loss development method, the paid Bornhuetter-Ferguson method and the reported Bornhuetter-Ferguson method. Any single method used to estimate ultimate losses has inherent advantages and disadvantages due to the trends and changes affecting the business environment and the Company’s administrative policies. Further, external factors, such as legislative changes, medical cost inflation, and others may directly or indirectly impact the relative adequacy of liabilities for unpaid losses and loss adjustment expenses. The Company’s approach is to select an estimate of ultimate losses based on comparing results of a variety of reserving methods, as opposed to total reliance on any single method. Unpaid loss and loss adjustment expenses are reviewed periodically for significant lines of business, and when current results differ from the original assumptions used to develop such estimates, the amount of the Company’s recorded liability for unpaid loss and loss adjustment expenses is adjusted. In the event the Company’s actual reported losses in any period are materially in excess of the previously estimated amounts, such losses, to the extent reinsurance coverage does not exist, could have a material adverse effect on the Company’s results of operations.

Receivables are amounts due from reinsurers, insureds and agents, and any sales of investment securities not yet settled, and comprised 14% of the Company’s total assets at December 31, 2020. Insured and agent balances are evaluated periodically for collectibility. Annually, the Company performs an analysis of the creditworthiness of the reinsurers with whom the Company contracts using various data sources. Failure of reinsurers to meet their obligations due to insolvencies, disputes or otherwise could result in uncollectible amounts and losses to the Company. Allowances for uncollectible amounts are established, as and when a loss has been determined probable, against the related receivable. Losses are recognized by the Company when determined on a specific account basis and a general provision for loss is made based on the Company’s historical experience.

Deferred acquisition costs comprised 10% of the Company’s total assets at December 31, 2020. Deferred acquisition costs are commissions, premium taxes, and other incremental direct costs of contract acquisition that results directly from and are essential to the contract transaction(s) and would not have been incurred by the Company had the contract transaction(s) not occurred. The deferred amounts are recorded as an asset on the balance sheet and amortized to expense in a systematic manner. Traditional life insurance and long-duration health insurance deferred policy acquisition costs are amortized over the estimated premium-paying period of the related policies using assumptions consistent with those used in computing the related liability for policy benefit reserves. Deferred acquisition costs for property and casualty insurance and short-duration health insurance are amortized over the effective period of the related insurance policies. Deferred policy acquisition costs are expensed when such costs are deemed not to be recoverable from future premiums (for traditional life and long-duration health insurance) and from the related unearned premiums and investment income (for property and casualty and short-duration health insurance). Assessments of recoverability for property and casualty and short-duration health insurance are extremely sensitive to the estimates of a subsequent year’s projected losses related to the unearned premiums. Projected loss estimates for a current block of business for which unearned premiums remain to be earned may vary significantly from the indicated losses incurred in any previous calendar year.

Deferred income taxes reflect the effect of temporary differences between assets and liabilities that are recognized for financial reporting purposes and the amounts that are recognized for tax purposes. These deferred income taxes are measured by applying currently enacted tax laws and rates. Valuation allowances are recognized to reduce the deferred tax asset to the amount that is deemed more likely than not to be realized. In assessing the likelihood of realization, management considers estimates of future taxable income and tax planning strategies.

Share-based transactions include employee and director share-based compensation awards. The Company determines a grant date fair value based on the price of our publicly-traded common stock and recognize the related compensation expense, adjusted for actual forfeitures, in the consolidated statement of operations on a straight-line basis over the requisite service period for the entire award. For non-employee share-based compensation awards, the Company recognizes the impact during the period of performance, and the fair value of the award is measured as of the date performance is complete, which is the vesting date.

Refer to Note 1 of Notes to Consolidated Financial Statements for details regarding the Company’s significant accounting policies.

Overall Corporate Results

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(In thousands)
 
Revenue
           
Property and Casualty:
           
American Southern
 
$
69,179
   
$
62,402
 
Life and Health:
               
Bankers Fidelity
   
127,144
     
131,611
 
Corporate and Other
   
(975
)
   
4,166
 
Total revenue
 
$
195,348
   
$
198,179
 
Income (loss) before income taxes
               
Property and Casualty:
               
American Southern
 
$
10,436
   
$
5,729
 
Life and Health:
               
Bankers Fidelity
   
12,430
     
(3,646
)
Corporate and Other
   
(7,363
)
   
(2,490
)
Income (loss) before income taxes
 
$
15,503
   
$
(407
)
Net income (loss)
 
$
12,169
   
$
(386
)

Management also considers and evaluates performance by analyzing the non-GAAP measure operating income or loss, and believes it is a useful metric for investors, potential investors, securities analysts and others because it isolates the “core” operating results of the Company before considering certain items that are either beyond the control of management (such as income tax expense, which is subject to timing, regulatory and rate changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company’s operational results (such as any realized or unrealized investment gains or losses, which are not a part of the Company’s primary operations and are, to a limited extent, subject to discretion in terms of timing of realization).

A reconciliation of net income (loss) to operating income (loss) is as follows:

 
Year Ended December 31,
 
 
2020
 
2019
 
 
(In thousands)
 
Reconciliation of Non-GAAP Financial Measure
       
         
Net income (loss)
 
$
12,169
   
$
(386
)
Income tax expense (benefit)
   
3,334
     
(21
)
Realized investment gains, net
   
(7,420
)
   
(1,574
)
Unrealized (gains) losses on equity securities, net
   
3,431
     
(5,511
)
Non-GAAP operating income (loss)
 
$
11,514
   
$
(7,492
)

On a consolidated basis, the Company had net income of $12.2 million, or $0.56 per diluted share, in 2020, compared to net loss of $0.4 million, or $0.04 per diluted share, in 2019. Operating income was $11.5 million in 2020 as compared to an operating loss of $7.5 million in 2019. The increase in operating income was primarily due to favorable loss experience in the life and health operations, resulting from a significant decrease in the number of incurred claims within the Medicare supplement line of business.  This decrease in the number of incurred claims was primarily attributable to the Company’s individual policy holders being subject to varying degrees of shelter in place orders instituted throughout the United States during 2020 as a result of COVID-19.

Total revenue was $195.3 million in 2020 as compared to $198.2 million in 2019. Premium revenue increased to $183.5 million in 2020 from $181.9 million in 2019. The increase in premium revenue was primarily due to an increase in the automobile physical damage line of business within the property and casualty operations in addition to life and other health lines in the life and health operations.  Partially offsetting the increase in premium revenue was a decrease in the Medicare supplement line of business in the life and health operations.

A more detailed analysis of the operating companies and other corporate activities follows.

UNDERWRITING RESULTS
American Southern

The following table summarizes, for the periods indicated, American Southern’s premiums, losses, expenses and underwriting ratios:

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(Dollars in thousands)
 
Gross written premiums
 
$
70,256
   
$
65,848
 
Ceded premiums
   
(5,890
)
   
(5,520
)
Net written premiums
 
$
64,366
   
$
60,328
 
Net earned premiums
 
$
62,372
   
$
58,680
 
Insurance benefits and losses incurred
   
39,339
     
39,541
 
Commissions and underwriting expenses
   
19,404
     
17,132
 
Underwriting income
 
$
3,629
   
$
2,007
 
Loss ratio
   
63.1
%
   
67.4
%
Expense ratio
   
31.1
     
29.2
 
Combined ratio
   
94.2
%
   
96.6
%

Gross written premiums at American Southern increased $4.4 million, or 6.7%, during 2020 as compared to 2019. The increase in gross written premiums was primarily attributable to an increase in premiums written in the automobile physical damage line of business due to a new agency that started in the second half of 2019, as well as increased writings from certain existing agencies. Also contributing to the increase in gross written premiums was an increase in premiums written in the general liability line of business related to new and existing programs. Partially offsetting the increase in gross written premiums was a decline in premiums written in the automobile liability line of business primarily attributable to the cancellation of certain programs and a return of premium to one account as a result of a decline of usage due to the impact of the COVID-19 pandemic.

Ceded premiums increased $0.4 million, or 6.7%, during 2020 as compared to 2019. American Southern’s ceded premiums are typically determined as a percentage of earned premiums and generally increase or decrease as earned premiums increase or decrease.  Also contributing to the increase in ceded premiums was an increase in earned premiums in certain accounts within the automobile physical damage and general liability lines of business, which are subject to reinsurance.

The following table summarizes, for the periods indicated, American Southern’s net earned premiums by line of business:

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(In thousands)
 
Automobile liability
 
$
30,312
   
$
30,649
 
Automobile physical damage
   
18,730
     
15,309
 
General liability
   
3,891
     
3,309
 
Surety
   
5,857
     
6,319
 
Other lines
   
3,582
     
3,094
 
Total
 
$
62,372
   
$
58,680
 

Net earned premiums increased $3.7 million, or 6.3%, during 2020 as compared to 2019. The increase in net earned premiums was primarily attributable to an increase in automobile physical damage coverage resulting from the new agency as previously mentioned. Premiums are earned ratably over their respective policy terms and therefore premiums earned in the current year are related to policies written during both the current year and immediately preceding year.

The performance of an insurance company is often measured by its combined ratio. The combined ratio represents the percentage of losses, loss adjustment expenses and other expenses that are incurred for each dollar of premium earned by the company. A combined ratio of under 100% represents an underwriting profit while a combined ratio of over 100% indicates an underwriting loss. The combined ratio is divided into two components, the loss ratio (the ratio of losses and loss adjustment expenses incurred to premiums earned) and the expense ratio (the ratio of expenses incurred to premiums earned).

Insurance benefits and losses incurred at American Southern decreased $0.2 million, or 0.5%, during 2020 as compared to 2019. As a percentage of premiums, insurance benefits and losses incurred were 63.1% in 2020 as compared to 67.4% in 2019. The decrease in the loss ratio was primarily due to a decline in the number and severity of claims in the automobile liability line of business as a result of the impact of the COVID-19 pandemic. Partially offsetting the decrease in the loss ratio was less favorable loss experience in the automobile physical damage line of business due to an increase in frequency of claims from the new agency.

Commissions and underwriting expenses increased $2.3 million, or 13.3%, during 2020 as compared to 2019. As a percentage of premiums, these expenses were 31.1% in 2020 as compared to 29.2% in 2019. The increase in the expense ratio was primarily due to an increase in fixed costs related to new business related to the new agency as previously mentioned. Also contributing to the increase in the expense ratio is American Southern’s use of a variable commission structure with certain agents, which compensates the participating agents in relation to the loss ratios of the business they write. During periods in which the loss ratio decreases, commissions and underwriting expenses will generally increase, and conversely, during periods in which the loss ratio increases, commissions and underwriting expenses will generally decrease.  In 2020, variable commissions at American Southern increased $0.1 million as compared to 2019 due to improved loss ratios from certain accounts subject to variable commissions.

In establishing reserves, American Southern initially reserves for losses at the higher end of the reasonable range if no other value within the range is determined to be more probable. Selection of such an initial loss estimate is an attempt by management to give recognition that initial claims information received generally is not conclusive with respect to legal liability, is generally not comprehensive with respect to magnitude of loss and generally, based on historical experience, will develop more adversely as time passes and more information becomes available. However, as a result, American Southern generally experiences reserve redundancies when analyzing the development of prior year losses in the current period. At December 31, 2020, the range of estimates developed in connection with the loss reserves for American Southern indicated that reserves could be as much as 13.5% lower or as much as 0.8% higher. Development from prior years’ reserves has historically reduced the current year loss ratio; however, such reduction in the current year loss ratio is generally offset by the reserves established in the current year for current period losses. Management believes that such differences will continue in future periods, but is unable to determine if or when incremental redundancies will increase or decrease until the underlying losses are ultimately settled.

Contingent commissions, if contractually applicable, are ultimately payable to participating agents based on the underlying profitability of a particular insurance contract or a group of insurance contracts, and are periodically evaluated and accrued as earned. In 2020, approximately 47% of American Southern’s earned premium provides for contractual commission arrangements which compensate the company’s agents in relation to the loss ratios of the business they write, compared to 44% in 2019. By structuring its business in this manner, American Southern provides its agents with an economic incentive to place profitable business with American Southern. In periods in which loss reserves reflect favorable development from prior years’ reserves, there is generally a highly correlated increase in commission expense also related to the prior year business. Accordingly, favorable loss development from prior years, while anticipated to continue in future periods, is not an indicator of significant additional profitability in the current year.

Bankers Fidelity

The following summarizes, for the periods indicated, Bankers Fidelity’s premiums, losses and expenses:

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(Dollars in thousands)
 
Medicare supplement
 
$
174,525
   
$
179,180
 
Other health products
   
9,218
     
7,817
 
Life insurance
   
9,348
     
8,509
 
Gross earned premiums
   
193,091
     
195,506
 
Ceded premiums
   
(71,924
)
   
(72,261
)
Net earned premiums
   
121,167
     
123,245
 
Insurance benefits and losses incurred
   
80,537
     
99,684
 
Commissions and underwriting expenses
   
34,177
     
35,573
 
Total expenses
   
114,714
     
135,257
 
Underwriting income (loss)
 
$
6,453
   
$
(12,012
)
Loss ratio
   
66.5
%
   
80.9
%
Expense ratio
   
28.2
     
28.9
 
Combined ratio
   
94.7
%
   
109.8
%

Net earned premium revenue at Bankers Fidelity decreased $2.1 million, or 1.7%, during 2020 as compared to 2019. Gross earned premiums from the Medicare supplement line of business decreased $4.7 million, or 2.6%, in 2020 as compared to 2019, due primarily to non-renewals exceeding the level of new business writings. Other health product premiums increased $1.4 million, or 17.9%, during 2020 as compared to 2019, primarily as a result of new sales of the company’s group health products. Gross earned premiums from the life insurance line of business increased $0.8 million, or 9.9%, in 2020 from 2019 due to an increase in the group life products premium. Partially offsetting the increase in gross earned premiums from the life insurance line was a decrease in individual life products premium, resulting from the redemption and settlement of existing individual life policy obligations exceeding the level of new individual life sales. Premiums ceded decreased $0.3 million, or 0.5%, in 2020 from 2019. The decrease in ceded premiums was due to a decrease in Medicare supplement premiums subject to the reinsurance agreement.

Insurance benefits and losses incurred decreased $19.1 million, or 19.2%, during 2020 as compared to 2019. As a percentage of premiums, benefits and losses were 66.5% in 2020 as compared to 80.9% in 2019. The decrease in the loss ratio was primarily due to a significantly lower number of claims incurred in the Medicare supplement line of business due to the Company’s individual policy holders being subject to varying degrees of shelter in place orders instituted throughout the United States during 2020 as a result of COVID-19. Also contributing to the decrease in the loss ratio was an improvement in rate adequacy in the Medicare supplement line of business as a result of implementation of rate increases on existing business.

Commissions and underwriting expenses decreased $1.4 million, or 3.9%, during 2020 as compared to 2019. As a percentage of earned premiums, these expenses were 28.2% in 2020 as compared to 28.9% in 2019. The decrease in the expense ratio was primarily due to a decrease in agent incentive costs and realization of costs saving initiatives, predominantly related to postage costs.  Also contributing to the decrease in the expense ratio was a decrease in expenses related to servicing the Medicare supplement line of business.

Net Investment Income and Realized Gains

Investment income decreased $1.2 million, or 13.8%, in 2020 as compared to 2019. The decrease in investment income was primarily attributable to a decrease in the equity in earnings from investments in the Company’s limited partnerships and limited liability companies of $0.9 million.

The Company had net realized investment gains of $7.4 million in 2020 as compared to net realized investment gains of $1.6 million in 2019. The net realized investment gains in 2020 were primarily attributable to gains of $6.9 million from the sale of the Company’s interest in a certain limited liability company as well as gains from the sale of a number of the Company’s investments in fixed maturities. The net realized investment gains in 2019 resulted from the disposition of certain of the Company’s investments in equity and fixed maturities. Management continually evaluates the Company’s investment portfolio and, as may be determined to be appropriate, makes adjustments for impairments and/or will divest investments. See Note 2 of Notes to Consolidated Financial Statements.

Unrealized Gains (Losses) on Equity Securities, Net

Investments in equity securities are measured at fair value at the end of the reporting period, with any changes in fair value reported in net income during the period. The Company recognized net unrealized losses on equity securities of $3.4 million and unrealized gains of $5.5 million during the years ended December 2020 and 2019, respectively. Changes in unrealized gains on equity securities for the applicable periods are primarily the result of fluctuations in the market value of certain of the Company’s equity securities.

Interest Expense

Interest expense decreased $0.5 million, or 24.4%, in 2020 as compared to 2019 due to a decrease in the average London Interbank Offered Rate (“LIBOR”) during the years ending 2020 and 2019, respectively, as the interest rates on the Company’s outstanding junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) are directly related to LIBOR.

Income Taxes

The primary differences between the effective tax rate and the federal statutory income tax rate for 2020 resulted from permanent differences related to meals & entertainment and vested stock grants.  Also contributing to differences between the effective tax rate and the federal statutory income tax rate were provision-to-filed return adjustments that are generally updated at the completion of the third quarter of each fiscal year and were $0.02 million in the year ended December 31, 2020.

The primary differences between the effective tax rate and the federal statutory income tax rate for 2019 resulted from permanent differences related to meals & entertainment and vested stock grants. Also contributing to differences between the effective tax rate and the federal statutory income tax rate was the dividends-received deduction (“DRD”). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from investments as well as the amount of the Company’s taxable income.

Liquidity and Capital Resources

The primary cash needs of the Company are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements. Current and expected patterns of claim frequency and severity may change from period to period, but generally are expected to continue within historical ranges. The Company’s primary sources of cash are written premiums, investment income and proceeds from the sale and maturity of its invested assets. The Company believes that, within each operating company, total invested assets will be sufficient to satisfy all policy liabilities and that cash inflows from investment earnings, future premium receipts and reinsurance collections will be adequate to fund the payment of claims and operating expenses as needed.

Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments, as described below, from the subsidiaries. The principal cash needs of the Parent are for the payment of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company’s board of directors from time to time. At December 31, 2020, the Parent had approximately $4.7 million of unrestricted cash and investments.

Dividend payments to a parent corporation by its wholly owned insurance subsidiaries are subject to annual limitations and are restricted to 10% of statutory surplus or statutory earnings before recognizing realized investment gains of the individual insurance subsidiaries. At December 31, 2020, the Parent’s insurance subsidiaries had an aggregate statutory surplus of $92.5 million. Dividends were paid to Atlantic American by its subsidiaries totaling $3.9 million and $4.8 million in 2020 and 2019, respectively.

The Parent provides certain administrative, purchasing and other services to each of its subsidiaries. The amount charged to and paid by the subsidiaries for these services was $6.7 million and $7.2 million in 2020 and 2019, respectively. In addition, the Parent has a formal tax-sharing agreement with each of its insurance subsidiaries. A net total of $1.8 million and $3.3 million were paid to the Parent under the tax sharing agreement in 2020 and 2019, respectively.

The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and investing the gross proceeds of the trust preferred securities in Junior Subordinated Debentures. The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the Company, and have an interest rate of three-month LIBOR plus an applicable margin. The margin ranges from 4.00% to 4.10%. At December 31, 2020, the effective interest rate was 4.28%. The obligations of the Company with respect to the issuances of the trust preferred securities represent a full and unconditional guarantee by the Parent of each trust’s obligations with respect to the trust preferred securities. Subject to certain exceptions and limitations, the Company may elect from time to time to defer Junior Subordinated Debenture interest payments, which would result in a deferral of distribution payments on the related trust preferred securities. The Company has not made such an election.

The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from potential future financing arrangements.

At December 31, 2020, the Company had 55,000 shares of Series D preferred stock (“Series D Preferred Stock”) outstanding. All of the shares of Series D Preferred Stock are held by an affiliate of the Company’s controlling shareholder. The outstanding shares of Series D Preferred Stock have a redemption value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company’s common stock at the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company’s common stock, subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company’s option. The Series D Preferred Stock is not currently convertible. The Company had accrued, but unpaid, dividends on the Series D Preferred Stock of $17,722 at December 31, 2020 and 2019. During each of 2020 and 2019, the Company paid Series D Preferred Stock dividends of $0.4 million.

During 2020, Bankers Fidelity Life Insurance Company (‘‘BFLIC”) became a member of the Federal Home Loan Bank of Atlanta (“FHLB”), for the primary purpose of enhancing financial flexibility. As a member, BFLIC can obtain access to low-cost funding and also receive dividends on FHLB stock. The membership arrangement established initial credit availability of five percent of statutory admitted assets, or approximately $8 million. Additional FHLB stock purchases may be required based upon the amount of funds borrowed from the FHLB.  BFLIC would be required to post acceptable forms of collateral for any borrowings it makes from the FHLB.  As of December 31, 2020, BFLIC had bonds with an amortized cost of $2.0 million pledged as collateral to FHLB.  To date, BFLIC has not made any borrowings from the FHLB.

Cash and cash equivalents increased from $12.9 million at December 31, 2019 to $19.3 million at December 31, 2020. The increase in cash and cash equivalents during 2020 was primarily attributable to an increase in net cash provided by operating activities of $9.0 million.  Partially offsetting the increase was $1.8 million in net investment purchases of securities exceeding sales and maturity of securities. Also partially offsetting the increase were dividends paid on the Company’s Series D Preferred Stock of $0.4 million.

The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, additional borrowings from financial institutions, will enable the Company to meet its liquidity requirements for the foreseeable future. Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse effect on the Company’s liquidity, capital resources or operations.

Expected Impact of COVID-19 on the Company’s Financial Condition and Results of Operations

The duration and ultimate impact of the COVID-19 pandemic is unknown at this time and it is not possible for us to reliably estimate the impact on the financial condition, operating results or liquidity of the Company and its operating subsidiaries in future periods.  However, we do not currently expect a significant decline in liquidity or operating results as a result of the disruption caused by the ongoing COVID-19 pandemic.  To date, the most significant impact of COVID-19 on the Company’s financial position has been volatility in the fair value of the Company’s fixed maturity and equity investments due to disruption in the financial markets, as well as a reduction in the frequency of medical claims.

We expect that earned premiums could be adversely impacted by a weakened economy leading to a slowdown in new sales and reduced retention of insureds.  Additionally, a number of states have issued bulletins that either encourage or require premium leniency such as extension of grace periods or moratoriums on cancellation of policies for non-payment.  The Company does not expect a significant reduction or delay in payments and continues to monitor state required actions as they develop.

For the Company’s property and casualty operations, the majority of premium revenue is derived from automobile liability and automobile physical damage lines of business written on a multi-year contract basis with state and local governments.  Although we cannot predict with any certainty at this time, we do not expect a significant level of cancellations or non-renewals of our property and casualty contracts in the short term but recognize that a prolonged economic slowdown could adversely affect future results.  During 2020, a certain automobile program was granted a partial premium refund as a result of a decline in usage.  However, the Company expects the aforementioned decline in usage to be temporary in nature.

Benefits and losses in our property and casualty operations could be adversely impacted as a result of disruption caused by the COVID-19 pandemic.  However, due to the nature of our primary product lines, the impact is not currently expected to be material.   As a result, we do not currently expect a material adverse effect on operating results or liquidity in the property and casualty operations.

The majority of premium revenue in our life and health operations are derived from the senior market segment of the population, or those individuals age sixty-five and up, who maintain Medicare supplement and to a lesser extent, whole life insurance policies with the Company.  We expect that earned premiums could be adversely impacted by the rise in unemployment and economic slowdown related to the COVID-19 pandemic and individual, business and government responses thereto, which could lead to a decline in new sales and reduced retention of insureds.  As a result, we currently anticipate that the life and health operations may experience a marginal decline in earned premiums although the actual impact cannot be predicted with certainty at this time.

Unforeseen infectious diseases that impact large portions of a population can have an adverse impact on mortality and morbidity, and resultant benefits and losses incurred by the Company’s life and health operations.  Accordingly, the Company does anticipate incurring higher costs, potentially similar to prior influenza seasons, as it relates to life insurance claims.  However, with much of the country sheltering in place over an extended period, the Company has experienced lower utilization of certain accident and health benefits, particularly in the Medicare supplement line of business.  As a result, and although the actual impact cannot be predicted with certainty at this time, the Company does not expect significant adverse development in total benefits and losses incurred in its life and health operations.

In addition to the information set forth in this report, you should carefully consider the discussions of the COVID-19 pandemic and related economic developments presented in our Annual Report on Form 10-K for the year ended 2019, our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020 and in other reports we file with the SEC from time to time, all of which could materially affect our business, financial condition or future results.

New Accounting Pronouncements

See “Recently Issued Accounting Standards” in Note 1 of Notes to Consolidated Financial Statements.

Impact of Inflation

Insurance premiums are established before the amount of losses and loss adjustment expenses, or the extent to which inflation may affect such losses and expenses, are known. Consequently, in establishing its premiums, the Company attempts to anticipate the potential impact of inflation. If, for competitive reasons, premiums cannot be increased to anticipate inflation, this cost would be absorbed by the Company. Inflation also affects the rate of investment return on the Company’s investment portfolio with a corresponding effect on investment income. To date, inflation has not had a material effect on the Company’s results of operations in any of the periods presented.

Off-Balance Sheet Arrangements

In the normal course of business, the Company has structured borrowings that, in accordance with accounting principles generally accepted in the United States of America, are recorded on the Company’s balance sheet at an amount that differs from the ultimate contractual obligation. See Note 8 of Notes to Consolidated Financial Statements.

Contractual Obligations

As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the table of contractual obligations required by this Item.

Item 7A.
Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

Item 8.
Financial Statements and Supplementary Data

INDEX TO FINANCIAL STATEMENTS

 
Page
ATLANTIC AMERICAN CORPORATION
 
   
23
   
25
   
26
   
27
   
28
   
29
   
30

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Shareholders
Atlantic American Corporation
Atlanta, Georgia

Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Atlantic American Corporation and subsidiaries (the Company) as of December 31, 2020 and 2019, and the related consolidated statements of operations, comprehensive income, shareholders’ equity and cash flows for each of the two years in the period ended December 31, 2020 and the related notes and schedules (collectively, referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles (GAAP).
 
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.  The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting.  As part of our audit we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.  Accordingly, we express no such opinion.
 
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
 
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
 
Valuation of Insurance Reserves for Losses and Claims (Claim Reserves)
 
As reflected on the consolidated balance sheet and discussed in Note 5 to the financial statements, the Company’s insurance reserves for losses and claims (claim reserves), were $79.1 million as of December 31, 2020. The Company’s claim reserves relate primarily to its property casualty lines of business and Medicare supplement business. The process of establishing claim reserves requires the use of estimates and judgments based on circumstances underlying the insured loss at the date of accrual. Management’s judgments include claims adjusters’ evaluations for unpaid claims reported prior to the close of the accounting period, estimates of incurred but not reported (IBNR) claims based on past experience and estimates of loss adjustment expenses.
 
The principal considerations for our determination that the valuation of claim reserves is a critical audit matter are the high degree of judgment and subjectivity in auditing the actuarial methods and assumptions used in the valuation process, including assumptions around expected loss ratios and reported and paid loss emergence patterns.
 
Addressing the matter involved performing the following audit procedures, among others:
 

Involving our actuarial specialists to assist in our procedures in:

o
Evaluating the appropriateness of management’s actuarial reserving methodologies and assumptions;

o
Evaluating management’s hindsight analyses;

o
Comparing management’s carried reserve to the range calculated by management’s specialist for property casualty claim reserves;

Testing the completeness and accuracy of data provided by management that served as the basis for the actuarial analyses on a sample basis; and

Evaluating movement of the Company’s recorded property casualty claim reserves within the Company’s estimated reserve range year over year.
 
Valuation of Insurance Reserves for Future Policy Benefits (Policy Reserves)
 
As reflected on the consolidated balance sheet and discussed in Note 5 to the financial statements, the Company’s insurance reserves for future policy benefits (policy reserves) were $90.9 million as of December 31, 2020. Policy reserves are related to life and health insurance policies and are based upon significant assumptions including future investment yields, mortality rates, withdrawal rates and expenses after giving effect to possible risks of unexpected claim experience.  These assumptions are based on historical experience modified as necessary to reflect anticipated trends and are generally established at contract inception.
 
The principal considerations for our determination that the valuation of policy reserves is a critical audit matter are the high degree of judgment required to assess certain assumptions that impact policy reserves and the complexity of the actuarial calculations.

Addressing the matter involved performing the following audit procedures, among others:


Involving our actuarial specialists to assist in our procedures in:

o
Evaluating whether the methodology applied by management is consistent in the aggregate with the methodology compliant with GAAP;

o
Assessing the significant assumptions used by management for new insurance contracts issued during the current year by comparing the significant assumptions noted above to historical experience, observable market data or management’s estimates of prospective changes to these assumptions;

o
Performing an independent recalculation of policy reserves for a sample of contracts for comparison to management’s estimate; and

o
Evaluating management’s loss recognition testing of aggregate reserve sufficiency.

Testing the completeness and accuracy of data used by management in developing assumptions on a sample basis.

/s/ Dixon Hughes Goodman LLP
We have served as the Company’s auditor since 2018.
Atlanta, Georgia
March 23, 2021

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED BALANCE SHEETS

   
December 31,
 
   
2020
   
2019
 
   
(Dollars in thousands,
except share data)
 
ASSETS
           
Cash and cash equivalents
 
$
19,319
   
$
12,893
 
Investments:
               
Fixed maturities, available-for-sale, at fair value (amortized cost: $222,461 and $219,233)
   
254,106
     
232,472
 
Equity securities, at fair value (cost: $6,393 and $7,168)
   
18,716
     
22,922
 
Other invested assets (cost: $3,765 and $9,908)
   
3,238
     
9,960
 
Policy loans
   
1,975
     
2,007
 
Real estate
   
38
     
38
 
Investment in unconsolidated trusts
   
1,238
     
1,238
 
Total investments
   
279,311
     
268,637
 
Receivables:
               
Reinsurance
   
29,086
     
32,135
 
Insurance premiums and other, net of allowance for doubtful accounts of $198 and $183 as of 2020 and 2019, respectively
   
27,512
     
13,134
 
Deferred income taxes, net
   
     
314
 
Deferred acquisition costs
   
39,611
     
38,861
 
Other assets
   
7,804
     
9,108
 
Intangibles
   
2,544
     
2,544
 
Total assets
 
$
405,187
   
$
377,626
 
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Insurance reserves and policyholder funds
               
Future policy benefits
 
$
90,872
   
$
92,490
 
Unearned premiums
   
27,131
     
26,035
 
Losses and claims
   
79,147
     
81,448
 
Other policy liabilities
   
1,526
     
1,933
 
Total insurance reserves and policyholder funds
   
198,676
     
201,906
 
Accounts payable and accrued expenses
   
26,412
     
23,588
 
Deferred income taxes, net
   
1,301
     
 
Junior subordinated debenture obligations, net
   
33,738
     
33,738
 
Total liabilities
   
260,127
     
259,232
 
Commitments and contingencies (Note 16)
               
Shareholders’ equity:
               
Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value
   
55
     
55
 
Common stock, $1 par, 50,000,000 shares authorized; 22,400,894 shares issued; 20,415,243 and 20,472,162 shares outstanding as of 2020 and 2019, respectively
   
22,401
     
22,401
 
Additional paid-in capital
   
57,437
     
57,820
 
Retained earnings
   
47,790
     
36,020
 
Accumulated other comprehensive income
   
25,000
     
10,459
 
Unearned stock grant compensation
   
(284
)
   
(781
)
Treasury stock, at cost, 1,985,651 and 1,928,732 shares as of 2020 and 2019, respectively
   
(7,339
)
   
(7,580
)
Total shareholders’ equity
   
145,060
     
118,394
 
Total liabilities and shareholders’ equity
 
$
405,187
   
$
377,626
 

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(Dollars in thousands,
except per share data)
 
Revenue:
           
Insurance premiums, net
 
$
183,539
   
$
181,925
 
Net investment income
   
7,744
     
8,979
 
Realized investment gains, net
   
7,420
     
1,574
 
Unrealized gains (losses) on equity securities, net
   
(3,431
)
   
5,511
 
Other income
   
76
     
190
 
Total revenue
   
195,348
     
198,179
 
                 
Benefits and expenses:
               
Insurance benefits and losses incurred
   
119,876
     
139,225
 
Commissions and underwriting expenses
   
46,811
     
45,477
 
Interest expense
   
1,610
     
2,130
 
Other expense
   
11,548
     
11,754
 
Total benefits and expenses
   
179,845
     
198,586
 
                 
Income (loss) before income taxes
   
15,503
     
(407
)
Income tax expense (benefit)
   
3,334
     
(21
)
Net Income (loss)
   
12,169
     
(386
)
Preferred stock dividends
   
(399
)
   
(399
)
Net Income (loss) applicable to common shareholders
 
$
11,770
   
$
(785
)
Earnings (loss) per common share (basic)
   
0.58
     
(0.04
)
Earnings (loss) per common share (diluted)
 
$
0.56
   
$
(0.04
)

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(Dollars in thousands)
 
Net income (loss)
 
$
12,169
   
$
(386
)
Other comprehensive income:
               
Available-for-sale fixed maturity securities:
               
Gross unrealized holding gain arising in the period
   
18,791
     
23,130
 
Related income tax effect
   
(3,946
)
   
(4,857
)
Subtotal
   
14,845
     
18,273
 
                 
Less: reclassification adjustment for net realized gains included in net income (loss)
   
(385
)
   
(353
)
Related income tax effect
   
81
     
74
 
Subtotal
   
(304
)
   
(279
)
                 
Total other comprehensive income, net of tax
   
14,541
     
17,994
 
Total comprehensive income
 
$
26,710
   
$
17,608
 

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

   
Year Ended December 31,
 
(Dollars in thousands, except per share data)
 
2020
   
2019
 
Preferred stock:
           
Balance, beginning of year
 
$
55
   
$
55
 
Balance, end of year
   
55
     
55
 
Common stock:
               
Balance, beginning of year
   
22,401
     
22,401
 
Balance, end of year
   
22,401
     
22,401
 
Additional paid-in capital:
               
Balance, beginning of year
   
57,820
     
57,414
 
Restricted stock grants, net of forfeitures; 20,000 and 355,000 restricted shares issued, as of 2020 and 2019, respectively
   
(376
)
   
396
 
Issuance of 4,701 and 10,862 shares, as of 2020 and 2019, respectively, under stock plans
   
(7
)
   
10
 
Balance, end of year
   
57,437
     
57,820
 
Retained earnings:
               
Balance, beginning of year
   
36,020
     
37,208
 
Net Income (loss)
   
12,169
     
(386
)
Dividends on common stock
   
     
(403
)
Dividends accrued on preferred stock
   
(399
)
   
(399
)
Balance, end of year
   
47,790
     
36,020
 
Accumulated other comprehensive income (loss):
               
Balance, beginning of year
   
10,459
     
(7,535
)
Other comprehensive income, net of tax
   
14,541
     
17,994
 
Balance, end of year
   
25,000
     
10,459
 
Unearned Stock Grant Compensation:
               
Balance, beginning of year
   
(781
)
   
(186
)
Restricted stock grants, net of forfeitures; 20,000 and 355,000 restricted shares issued, as of 2020 and 2019, respectively
   
60
     
(948
)
Amortization of unearned compensation
   
437
     
353
 
Balance, end of year
   
(284
)
   
(781
)
Treasury Stock:
               
Balance, beginning of year
   
(7,580
)
   
(7,985
)
Restricted stock grants, net of forfeitures; 20,000 and 355,000 restricted shares issued, as of 2020 and 2019, respectively
   
316
     
552
 
Purchase of 0 and 26,210 shares, as of 2020 and 2019, respectively, for treasury
   
     
(71
)
Net shares acquired related to employee share-based compensation plans
   
(91
)
   
(92
)
Issuance of 4,701 and 10,862 shares, as of 2020 and 2019, respectively,  shares under stock plans
   
16
     
16
 
Balance, end of year
   
(7,339
)
   
(7,580
)
                 
Total shareholders’ equity
 
$
145,060
   
$
118,394
 
Dividends declared on common stock per share
 
$
   
$
(.02
)

See the accompanying notes to the consolidated financial statements.

ATLANTIC AMERICAN CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(Dollars in thousands)
 
Cash flows from operating activities:
           
Net Income (loss)
 
$
12,169
   
$
(386
)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
               
Amortization of deferred acquisition costs
   
19,393
     
17,288
 
Acquisition costs deferred
   
(20,143
)
   
(19,055
)
Realized investment gains, net
   
(7,420
)
   
(1,574
)
Unrealized (gains) losses on equity securities, net
   
3,431
     
(5,511
)
Distributions received from equity method investees
   
     
379
 
Compensation expense related to share awards
   
437
     
353
 
Depreciation and amortization
   
980
     
996
 
Deferred income tax benefit
   
(2,250
)
   
(913
)
(Increase) decrease in receivables, net
   
1,349

   
(4,709
)
Increase (decrease) in insurance reserves and policyholder funds
   
(3,230
)
   
12,858
 
Increase in accounts payable and accrued expenses
   
2,324
     
3,472
 
Other, net
   
1,931
     
(5,005
)
Net cash provided by (used in) operating activities
   
8,971

   
(1,807
)
                 
Cash flows from investing activities:
               
Proceeds from investments sold
   
18,541
     
120,950
 
Proceeds from investments matured, called or redeemed
   
7,117
     
6,157
 
Investments purchased
   
(27,489
)
   
(124,029
)
Additions to property and equipment
   
(233
)
   
(69
)
Net cash (used in) provided by  investing activities
   
(2,064
)
   
3,009
 
                 
Cash flows from financing activities:
               
Payment of dividends on Series D preferred stock
   
(399
)
   
(399
)
Payment of dividends on common stock
   
     
(403
)
Proceeds from shares issued under stock plans
   
9
     
26
 
Treasury stock acquired — share repurchase authorization
   
     
(71
)
Treasury stock acquired — net employee share-based compensation
   
(91
)
   
(92
)
Net cash used in financing activities
   
(481
)
   
(939
)
                 
Net increase in cash
   
6,426
     
263
 
Cash and cash equivalents at beginning of year
   
12,893
     
12,630
 
Cash and cash equivalents at end of year
 
$
19,319
   
$
12,893
 
                 
Supplemental cash flow information:
               
Cash paid for interest
 
$
1,665
   
$
2,155
 
Cash paid for income taxes
 
$
3,883
   
$
1,662
 
Non-cash investing activities:
               
Receivable from sale of other invested assets
  $ 12,678
    $ -
 

See the accompanying notes to the consolidated financial statements.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in thousands, except per share amounts)

Note 1.
Summary of Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) which, for insurance companies, differ in some respects from the statutory accounting practices prescribed or permitted by regulatory authorities. These financial statements include the accounts of Atlantic American Corporation (“Atlantic American” or the “Parent”) and its subsidiaries (collectively with the Parent, the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation. Operating results achieved in any historical period are not necessarily indicative of results to be expected in any future period.

At December 31, 2020, the Parent owned four insurance subsidiaries, Bankers Fidelity Life Insurance Company and its wholly-owned subsidiary, Bankers Fidelity Assurance Company (together known as “Bankers Fidelity”), and American Southern Insurance Company and its wholly-owned subsidiary, American Safety Insurance Company (together known as “American Southern”), in addition to one non-insurance subsidiary, xCalibre Risk Services, Inc. The Parent has issued a guarantee of all liabilities of Bankers Fidelity.

Premium Revenue and Cost Recognition

Life insurance premiums are recognized as revenue when due; accident and health insurance premiums are recognized as revenue over the premium paying period and property and casualty insurance premiums are recognized as revenue over the period of the contract in proportion to the amount of insurance protection provided. Losses, benefits and expenses are accrued as incurred and are associated with premiums as they are earned so as to result in recognition of profits over the lives of the contracts. For traditional life insurance and long-duration health insurance, this association is accomplished by the provision of a future policy benefits reserve and the deferral and subsequent amortization of the costs of acquiring business, which are referred to as “deferred policy acquisition costs” (principally commissions, premium taxes, and other incremental direct costs of issuing policies). Deferred policy acquisition costs (“DAC”) are amortized over the estimated premium-paying period of the related policies using assumptions consistent with those used in computing the future policy benefits reserve. The Company provides for insurance benefits and losses on accident, health, and property-casualty claims based upon estimates of projected ultimate losses. DAC for property and casualty insurance and short-duration health insurance is amortized over the effective period of the related insurance policies. Contingent commissions, if contractually applicable, are ultimately payable to agents based on the underlying profitability of a particular insurance contract or a group of insurance contracts, and are periodically evaluated and accrued as earned. In periods in which revisions are made to the estimated loss reserves related to the particular insurance contract or group of insurance contracts subject to such commissions, corresponding adjustments are also made to the related accruals. DAC is expensed when such costs are deemed not to be recoverable from future premiums (for traditional life and long-duration health insurance) and from the related unearned premiums and investment income (for property and casualty and short-duration health insurance).

Intangibles

Intangibles consist of goodwill and other indefinite-lived intangible assets. Goodwill represents the excess of cost over the fair value of net assets acquired and is not amortized. Other indefinite-lived intangibles represent the value of licenses and are not amortized. The Company periodically reviews its goodwill and other indefinite-lived intangibles to determine if any adverse conditions exist that could indicate impairment. Conditions that could trigger impairment include, but are not limited to, a significant change in business climate that could affect the value of the related asset, an adverse action, or an assessment by a regulator. No impairment of the Company’s recorded intangibles was identified during any of the periods presented.

Investments

The Company’s investments in fixed maturities, which include bonds and redeemable preferred stocks, are classified as “available-for-sale” and, accordingly, are carried at fair value with the after-tax difference from amortized cost, as adjusted if applicable, reflected in shareholders’ equity as a component of accumulated other comprehensive income or loss. The Company’s equity securities, which include common and non-redeemable preferred stocks, are carried at fair value with changes in fair value reported in net income. The fair values of fixed maturities and equity securities are largely determined from publicly quoted market prices, when available, or independent broker quotations. As of December 31, 2020, the Company owned a certain equity security in the amount of $143, with a valuation that was derived from techniques in which one or more of the significant inputs are unobservable. As of December 31, 2020, all fixed maturities were valued using publicly quoted market prices or techniques with observable inputs. Values that are not determined using quoted market prices inherently involve a greater degree of judgment and uncertainty and therefore ultimately greater price volatility than the value of securities with publicly quoted market prices. Policy loans are carried at unpaid principal balance and real estate is carried at historical cost. Other invested assets are comprised of investments in limited partnerships, limited liability companies, and real estate joint ventures, and are accounted for using the equity method. If the value of a fixed maturity security or other invested asset declines below its cost or amortized cost, as applicable, and the decline is considered to be other than temporary, a realized loss is recorded to reduce the carrying value of the investment to its estimated fair value, which becomes the new cost basis.

Premiums and discounts related to investments are amortized or accreted over the life of the related investment as an adjustment to yield using the effective interest method. Dividends and interest income are recognized when earned or declared. The cost of securities sold is based on specific identification. Unrealized gains (losses) in the value of fixed maturities are accounted for as a direct increase (decrease) in accumulated other comprehensive income in shareholders’ equity, net of deferred tax and, accordingly, have no effect on net income.

Income Taxes

Deferred income taxes represent the expected future tax consequences when the reported amounts of assets and liabilities are recovered or paid. They arise from differences between the financial reporting and tax basis of assets and liabilities and are adjusted for changes in tax laws and tax rates as those changes are enacted. The provision for income taxes represents the total amount of income taxes due related to the current year, plus the change in deferred income taxes during the year. A valuation allowance is recognized if, based on management’s assessment of the relevant facts, it is more likely than not that some portion of a deferred tax asset will not be realized.

Earnings Per Common Share

Basic earnings per common share are based on the weighted average number of common and participating shares outstanding during the relevant period. Diluted earnings per common share are based on the weighted average number of common and participating shares outstanding during the relevant period, plus options outstanding, if applicable, using the treasury stock method and the assumed conversion of the Series D preferred stock, if dilutive. Unless otherwise indicated, earnings per common share amounts are presented on a diluted basis.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on hand and investments in short-term, highly liquid securities with original maturities of three months or less from date of purchase.

Reinsurance

The Company enters into reinsurance agreements with other companies in the normal course of business. For each reinsurance agreement, the Company determines if the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Reinsurance premiums and benefits paid or provided are accounted for on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. Premiums, benefits and DAC are reported net of insurance ceded. Reinsurance premiums from assumed business are estimated based on information received from ceding companies and reinsureds.  Any subsequent differences that arise regarding such estimates are recorded in the period in which they are determined.
 
Share-Based Transactions

For employee and director share-based compensation awards, the Company determines a grant date fair value based on the price of our publicly-traded common stock and recognize the related compensation expense, adjusted for actual forfeitures, in the consolidated statement of operations on a straight-line basis over the requisite service period for the entire award. For non-employee share-based compensation awards, the Company recognizes the impact during the period of performance, and the fair value of the award is measured as of the date performance is complete, which is the vesting date.

Treasury Stock

Treasury stock is reflected as a reduction of shareholders’ equity at cost. The Company uses the first-in-first-out (“FIFO”) purchase cost to determine the cost of treasury stock that is reissued. The Company includes any gains and losses in additional paid-in capital when treasury stock is reissued.

Recently Issued Accounting Standards

Adoption of New Accounting Standards

Fair Value Measurement – Changes to the Disclosure Requirements for Fair Value Measurement. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). This guidance removes the following disclosure requirements from Topic 820: (1) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (2) the policy for timing of transfers between levels, and (3) the valuation processes for Level 3 fair value measurements. This disclosure also includes the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements.  The Company adopted ASU 2018-13 as of January 1, 2020. The adoption of this ASU did not have an impact on the Company’s consolidated financial statements.

Goodwill. In January 2017, the FASB issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”).  ASU 2017-04 is intended to simplify the evaluation of goodwill.  The updated guidance requires recognition and measurement of goodwill impairment based on the excess of the carrying value of the reporting unit compared to its estimated fair value, with the amount of the impairment not to exceed the carrying value of the reporting unit’s goodwill. Under the prior accounting guidance, if the reporting unit’s carrying value exceeds its estimated fair value, the Company allocates the fair value of the reporting unit to all of the assets and liabilities of the reporting unit to determine an implied goodwill value. An impairment loss is then recognized for the excess, if any, of the carrying value of the reporting unit’s goodwill compared to the implied goodwill value.  The Company adopted ASU 2017-04 as of January 1, 2020. The adoption of this ASU did not have an impact on the Company’s consolidated financial statements.

Future Adoption of New Accounting Standards

Reference Rate Reform. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). This guidance provides optional expedients and exceptions for applying GAAP to investments, derivatives, or other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. Along with the optional expedients, the amendments include a general principle that permits an entity to consider contract modifications due to reference reform to be an event that does not require contract re-measurement at the modification date or reassessment of a previous accounting determination. Additionally, a company may make a one-time election to sell, transfer, or both sell and transfer debt securities classified as held to maturity that reference a rate affected by reference rate reform and that were classified as held to maturity before January 1, 2020. This standard may be elected over time through December 31, 2022 as reference rate reform activities occur. The Company is currently assessing the effect of adopting this guidance on its financial condition and results of operations.

Investments – Equity Securities. In January 2020, the FASB issued ASU No. 2020-01 (“ASU 2020-01”) Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This update, among others, clarifies the interaction of the accounting for equity securities under Topic 321 and investments under the equity method of accounting in Topic 323 when there is a change in level of ownership or degree of influence. ASU 2020-01 is effective for the Company beginning with the first quarter of 2021 and will be applied prospectively. Early adoption is permitted. This guidance is not expected to have a material impact on the Company’s consolidated financial statements.

Income Taxes – Simplifying the Accounting for Income Taxes. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). This updated guidance is intended to simplify the accounting for income taxes by removing several exceptions contained in existing guidance and amending other existing guidance to simplify several other income tax accounting matters. The updated guidance is effective for interim and annual reporting periods beginning after December 15, 2020, although earlier adoption is permitted. The Company expects to adopt the updated guidance January 1, 2021, and does not expect the adoption of this ASU to have a material impact on its consolidated financial statements.

Accounting for Long-Duration Contracts. In August 2018, the FASB issued ASU No. 2018-12, Financial Services —Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”). This guidance (1) improves the timeliness of recognizing changes in the liability for future policy benefits and modifies the rate used to discount future cash flows, (2) simplifies and improves the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts, (3) simplifies the amortization of deferred acquisition costs, and (4) improves the effectiveness of the required disclosures. ASU 2018-12 is effective for interim and annual reporting periods beginning after December 15, 2024, although earlier adoption is permitted. The Company has not yet determined the method or timing for adoption or estimated the impact on the Company’s consolidated financial statements.

Financial Instruments – Credit Losses. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires entities to measure all expected credit losses for financial instruments (including reinsurance recoverable and policy loans) held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Under current GAAP, entities generally recognize credit losses when it is probable that the loss has been incurred. ASU 2016-13 will remove all recognition thresholds and will require entities to recognize an allowance for credit losses equal to the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the entity expects to collect over the instrument’s contractual life. ASU 2016-13 also amends the credit loss measurement guidance for available-for-sale (“AFS”) debt securities and beneficial interests in securitized financial assets. Credit losses on AFS debt securities carried at fair value will continue to be measured as an other than temporary impairment (“OTTI”) when incurred; however, the losses will be recognized through an allowance and no longer as an adjustment to the cost basis. Recoveries of OTTI will be recognized as reversals of valuation allowances and no longer accreted as investment income through an adjustment to the investment yield. The allowance on AFS debt securities cannot cause the net carrying value to be below fair value and, therefore, it is possible that increases in fair value due to decreases in market interest rates could cause the reversal of a valuation allowance and increase net income. The new guidance will also require purchased financial assets with a more-than-insignificant amount of credit deterioration since original issuance to be recorded based on contractual amounts due and an initial allowance recorded at the date of purchase. For the Company, the amendments in ASU 2016-13 will be effective for interim and annual reporting periods beginning after December 15, 2022. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company has not yet determined the timing of adoption. Implementation matters yet to be addressed include determining the impact of valuation allowances on the effective interest method for recognizing interest income from AFS debt securities as well as updating our investment accounting system functionality to adjust valuation allowances based on changes in fair value. The estimated effect on the Company’s consolidated financial statements can only be estimated based on the current investment portfolio at any given point in time, and accordingly, has not currently been determined.

Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Significant estimates and assumptions are used in developing and evaluating deferred income taxes, deferred acquisition costs, insurance reserves, investments, and receivables, among others, and actual results could differ materially from management’s estimates.

Note 2.
Investments

The following tables set forth the estimated fair value, gross unrealized gains, gross unrealized losses and cost or amortized cost of the Company’s investments in fixed maturities and equity securities, aggregated by type and industry, as of December 31, 2020 and December 31, 2019.

Fixed maturities were comprised of the following:

   
2020
 
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Amortized
Cost
 
Fixed maturities:
                       
Bonds:
                       
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
30,762
   
$
1,381
   
$
26
   
$
29,407
 
Obligations of states and political subdivisions
   
11,802
     
898
     
     
10,904
 
Corporate securities:
                               
Utilities and telecom
   
30,359
     
4,423
     
     
25,936
 
Financial services
   
78,258
     
9,811
     
6
     
68,453
 
Other business – diversified
   
41,145
     
5,689
     
15
     
35,471
 
Other consumer – diversified
   
61,530
     
9,479
     
47
     
52,098
 
Total corporate securities
   
211,292
     
29,402
     
68
     
181,958
 
Redeemable preferred stocks:
                               
Other consumer – diversified
   
250
     
58
     
     
192
 
Total redeemable preferred stocks
   
250
     
58
     
     
192
 
Total fixed maturities
 
$
254,106
   
$
31,739
   
$
94
   
$
222,461
 

   
2019
 
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Amortized
Cost
 
Fixed maturities:
                       
Bonds:
                       
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
20,259
   
$
467
   
$
53
   
$
19,845
 
Obligations of states and political subdivisions
   
11,940
     
371
     
53
     
11,622
 
Corporate securities:
                               
Utilities and telecom
   
26,648
     
2,404
     
32
     
24,276
 
Financial services
   
73,917
     
4,249
     
57
     
69,725
 
Other business – diversified
   
41,706
     
2,335
     
98
     
39,469
 
Other consumer – diversified
   
57,752
     
3,702
     
54
     
54,104
 
Total corporate securities
   
200,023
     
12,690
     
241
     
187,574
 
Redeemable preferred stocks:
                               
Other consumer – diversified
   
250
     
58
     
     
192
 
Total redeemable preferred stocks
   
250
     
58
     
     
192
 
Total fixed maturities
 
$
232,472
   
$
13,586
   
$
347
   
$
219,233
 

Bonds having an amortized cost of $10,670 and $10,669 and included in the tables above were on deposit with insurance regulatory authorities at December 31, 2020 and 2019, respectively, in accordance with statutory requirements.  Additionally, bonds having an amortized cost of $1,997 and $0 and included in the tables above were pledged as collateral to FHLB at December 31, 2020 and 2019, respectively.

   
2020
 
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Cost or
Amortized
Cost
 
Equity securities:
                       
Common and non-redeemable preferred stocks:
                       
Financial services
   
2,111
     
351
     
     
1,760
 
Other business – diversified
   
16,605
     
11,972
     
     
4,633
 
Total equity securities
 
$
18,716
   
$
12,323
   
$
   
$
6,393
 

   
2019
 
   
Estimated
Fair Value
   
Gross
Unrealized
Gains
   
Gross
Unrealized
Losses
   
Cost or
Amortized
Cost
 
Equity securities:
                       
Common and non-redeemable preferred stocks:
                       
Financial services
   
3,159
     
624
     
     
2,535
 
Other business – diversified
   
19,763
     
15,130
     
     
4,633
 
Total equity securities
 
$
22,922
   
$
15,754
   
$
   
$
7,168
 

The carrying value and amortized cost of the Company’s investments in fixed maturities at December 31, 2020 and 2019 by contractual maturity were as follows. Actual maturities may differ from contractual maturities because issuers may call or prepay obligations with or without call or prepayment penalties.

   
2020
   
2019
 
   
Carrying
Value
   
Amortized
Cost
   
Carrying
Value
   
Amortized
Cost
 
Due in one year or less
 
$
2,041
   
$
2,015
   
$
   
$
 
Due after one year through five years
   
18,373
     
17,039
     
14,664
     
14,280
 
Due after five years through ten years
   
89,892
     
79,993
     
77,934
     
73,521
 
Due after ten years
   
124,609
     
104,527
     
130,680
     
122,321
 
Asset backed securities
   
19,191
     
18,887
     
9,194
     
9,111
 
Totals
 
$
254,106
   
$
222,461
   
$
232,472
   
$
219,233
 

The following tables present the Company’s unrealized loss aging for securities by type and length of time the security was in a continuous unrealized loss position as of December 31, 2020 and 2019.

   
2020
 
   
Less than 12 months
   
12 months or longer
   
Total
 
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
 
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
7,045
   
$
26
   
$
   
$
   
$
7,045
   
$
26
 
Corporate securities
   
4,602
     
68
     
     
     
4,602
     
68
 
Total temporarily impaired securities
 
$
11,647
   
$
94
   
$
   
$
   
$
11,647
   
$
94
 

   
2019
 
   
Less than 12 months
   
12 months or longer
   
Total
 
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
   
Fair
Value
   
Unrealized
Losses
 
U.S. Treasury securities and obligations of U.S. Government agencies and authorities
 
$
3,432
   
$
22
   
$
3,533
   
$
31
   
$
6,965
   
$
53
 
Obligations of states and political subdivisions
   
3,106
     
53
     
     
     
3,106
     
53
 
Corporate securities
   
23,245
     
145
     
2,504
     
96
     
25,749
     
241
 
Total temporarily impaired securities
 
$
29,783
   
$
220
   
$
6,037
   
$
127
   
$
35,820
   
$
347
 

The evaluation for an OTTI is a quantitative and qualitative process, which is subject to risks and uncertainties in the determination of whether declines in the fair value of investments are other than temporary. Potential risks and uncertainties include, among other things, changes in general economic conditions, an issuer’s financial condition or near term recovery prospects and the effects of changes in interest rates. In evaluating a potential impairment, the Company considers, among other factors, management’s intent and ability to hold the securities until price recovery, the nature of the investment and the expectation of prospects for the issuer and its industry, the status of an issuer’s continued satisfaction of its obligations in accordance with their contractual terms, and management’s expectation as to the issuer’s ability and intent to continue to do so, as well as ratings actions that may affect the issuer’s credit status.

There were no OTTI charges recorded during the years ended December 31, 2020 and  2019.

As of December 31, 2020 and 2019, there were twenty and thirty securities, respectively, in an unrealized loss position which primarily included certain of the Company’s investments in fixed maturities within the financial services, other diversified business and other diversified consumer sectors. The decrease in the number and value of securities in an unrealized loss position during the year ended December 31, 2020, was primarily attributable to improvement in market values in certain of the Company’s fixed maturity securities as a result of a declining interest rate environment.  The Company does not currently intend to sell nor does it expect to be required to sell any of the securities in an unrealized loss position. Based upon the Company’s expected continuation of receipt of contractually required principal and interest payments and its intent and ability to retain the securities until price recovery, as well as the Company’s evaluation of other relevant factors, including those described above, the Company has deemed these securities to be temporarily impaired as of December 31, 2020.

Investment income was earned from the following sources:

   
2020
   
2019
 
Fixed maturities
 
$
8,646
   
$
8,485
 
Equity securities
   
141
     
282
 
Other
   
(788
)
   
319
 
     
7,999
     
9,086
 
Investment expenses
   
255
     
107
 
Net investment income
 
$
7,744
   
$
8,979
 

A summary of realized investment gains (losses) follows:

   
2020
 
   
Fixed
Maturities
   
Equity
Securities
   
Other
Invested Assets
   
Total
 
Gains
 
$
835
   
$
88
   
$
6,948
   
$
7,871
 
Losses
   
(450
)
   
(1
)
   
     
(451
)
Realized investment gains, net
 
$
385
   
$
87
   
$
6,948
   
$
7,420
 

   
2019
 
   
Fixed
Maturities
   
Equity
Securities
   
Other
Invested Assets
   
Total
 
Gains
 
$
2,003
   
$
1,221
   
$
   
$
3,224
 
Losses
   
(1,650
)
   
     
     
(1,650
)
Realized investment gains, net
 
$
353
   
$
1,221
   
$
   
$
1,574
 

Proceeds from the sales of available-for-sale fixed maturities were as follows:

   
2020
   
2019
 
Sales proceeds
 
$
18,504
   
$
117,530
 
Gross gains
   
835
     
2,003
 
Gross losses
   
(450
)
   
(1,650
)

Proceeds from the sales of available-for-sale equity securities were as follows:

   
2020
   
2019
 
Sales proceeds
 
$
5
   
$
2,568
 
Gross gains
   
     
1,113
 
Gross losses
   
(1
)
   
 

Sales of available-for-sale securities in 2020 and 2019 were primarily a result of improving the overall risk versus return profile of the portfolio. In addition, the Company sold its interest in a certain limited liability company held as other invested assets to a third-party.  The transaction closed prior to December 31, 2020.  The Company recorded gross realized gains on this sale of $6.9 million and proceeds of $12.7 million which settled after year end.
 
The following table presents the portion of unrealized gains (losses) related to equity securities still held for the years ended December 31, 2020 and 2019.

   
2020
   
2019
 
Net realized and unrealized gains (losses) recognized during the period on equity securities
 
$
(3,344
)
 
$
6,732
 
Less: Net realized gains (losses) recognized during the period on equity securities sold during the period
   
87
     
1,221
 
Unrealized gains (losses) on equity securities, net
 
$
(3,431
)
 
$
5,511
 

The Company’s bond portfolio included 97% investment grade securities, as defined by the NAIC, at December 31, 2020.

Variable Interest Entities

The Company holds passive interests in a number of entities that are considered to be variable interest entities ("VIEs") under GAAP guidance. The Company’s VIE interests principally consist of interests in limited partnerships and limited liability companies formed for the purpose of achieving diversified equity returns. The Company’s VIE interests, carried as a part of other invested assets, totaled $3,238 and $9,960 at December 31, 2020 and 2019, respectively. The Company’s VIE interests, carried as a part of investment in unconsolidated subsidiaries, totaled $1,238 at December 31, 2020 and 2019.

The Company does not have power over the activities that most significantly impact the economic performance of these VIEs and thus is not the primary beneficiary. Therefore, the Company has not consolidated these VIEs. The Company’s involvement with each VIE is limited to its direct ownership interest in the VIE. The Company has no arrangements with any of the VIEs to provide other financial support to or on behalf of the VIE. The Company’s maximum loss exposure relative to these investments was limited to the carrying value of the Company’s investment in the VIEs, which amount to $4,476 and $11,198, at December 31, 2020 and 2019, respectively. As of December 31, 2020 and 2019, the Company had outstanding commitments totaling $1,997, whereby the Company is committed to fund these investments and may be called by such VIEs during the commitment period to fund the purchase of new investments and partnership expenses.


Note 3.
Disclosures About Fair Value of Financial Instruments

The estimated fair values have been determined by the Company using available market information from various market sources and appropriate valuation methodologies as of the respective dates. However, considerable judgment is necessary to interpret market data and to develop the estimates of fair value. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, the estimates presented herein are not necessarily indicative of the amounts which the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

The following describes the fair value hierarchy and provides information as to the extent to which the Company uses fair value to measure the value of its financial instruments and information about the inputs used to value those financial instruments. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad levels.


Level 1
Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company’s financial instruments valued using Level 1 criteria include cash equivalents and exchange traded common stocks.


Level 2
Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company’s financial instruments valued using Level 2 criteria include significantly most of its fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers. Prices for the majority of the Company’s Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.


Level 3
Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company’s best estimate of an amount that could be realized in a market exchange for the asset or liability. The Company’s financial instruments valued using Level 3 criteria consist of one fixed maturity security and one equity security.  As of December 31, 2020 and December 31, 2019, the value of the fixed maturity valued using Level 3 criteria was $0 for both years. As of December 31, 2020 and December 31, 2019, the value of the equity security valued using Level 3 criteria was $143 and $0, respectively.   The equity security is not traded and valued at cost. The use of different criteria or assumptions regarding data may have yielded materially different valuations.

Recurring Fair Value Measurements

Cash Equivalents. The carrying amount approximates fair value due to the short-term nature of the instruments.

Fixed Maturities and Common and Non-Redeemable Preferred Stocks. The carrying amount is determined from publicly quoted market prices. Certain fixed maturities do not have publicly quoted values and consist solely of issuances of pooled debt obligations of multiple, smaller financial services companies. They are not actively traded and valuation techniques used to measure fair value are based on future estimated cash flows discounted at reasonable estimated rates of interest. Other qualitative and quantitative information is also considered, as applicable.

Nonrecurring Fair Value Measurements

Non-publicly Traded Invested Assets. The fair value of investments in certain limited partnerships which are included in other invested assets on the consolidated balance sheet were determined by officers of those limited partnerships.

Policy Loans. Policy loans, which are categorized as Level 2 fair value measurements, are carried at the unpaid principal balances.

Junior Subordinated Debentures. The fair value is estimated based on observable interest rates and yields for debt instruments having similar characteristics.

As of December 31, 2020, financial instruments carried at fair value were measured on a recurring basis as summarized below:

Assets:
 
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
Fixed maturities
 
$
   
$
254,106
   
$
   
$
254,106
 
Equity securities
   
18,573
     
     
143
     
18,716
 
Cash equivalents
   
12,010
     
     
     
12,010
 
Total
 
$
30,583
   
$
254,106
   
$
143
   
$
284,832
 

As of December 31, 2019, financial instruments carried at fair value were measured on a recurring basis as summarized below:

Assets:
 
Quoted Prices in
Active Markets
for Identical Assets
(Level 1)
   
Significant
Other Observable
Inputs
(Level 2)
   
Significant
Unobservable
Inputs
(Level 3)
   
Total
 
Fixed maturities
 
$
   
$
232,472
   
$
   
$
232,472
 
Equity securities
   
22,922
     
     
     
22,922
 
Cash equivalents
   
7,173
     
     
     
7,173
 
Total
 
$
30,095
   
$
232,472
   
$
   
$
262,567
 

The Company does not have any fixed maturities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of years ended December 31, 2020 and 2019.

The following table sets forth the carrying amount, estimated fair value and level within the fair value hierarchy of the Company’s financial instruments as of December 31, 2020 and 2019.

   
Level in
   
2020
   
2019
 
   
Fair Value
Hierarchy(1)
   
Carrying
Amount
   
Estimated
Fair Value
   
Carrying
Amount
   
Estimated
Fair Value
 
Assets:
                             
Cash and cash equivalents
 
Level 1
   
$
19,319
   
$
19,319
   
$
12,893
   
$
12,893
 
Fixed maturities
 
(1)
   
254,106
     
254,106
     
232,472
     
232,472
 
Equity securities
 
(1)
   
18,716
     
18,716
     
22,922
     
22,922
 
Other invested assets
 
Level 3
     
3,238
     
3,238
     
9,960
     
9,960
 
Policy loans
 
Level 2
     
1,975
     
1,975
     
2,007
     
2,007
 
Investments in unconsolidated trusts
 
Level 2
     
1,238
     
1,238
     
1,238
     
1,238
 
                                         
Liabilities:
                                       
Junior Subordinated Debentures, net
 
Level 2
     
33,738
     
32,297
     
33,738
     
35,977
 

(1)
See the aforementioned information for a description of the fair value hierarchy as well as a disclosure of levels for classes of these financial assets.


Note 4.
Deferred Policy Acquisition Costs

The following table presents a rollforward of deferred policy acquisition costs by segment for the years ended December 31.

   
2020
   
2019
 
   
American
Southern
   
Bankers
Fidelity
   
American
Southern
   
Bankers
Fidelity
 
Deferred policy acquisition costs:
                       
Balance, beginning of year
 
$
1,979
   
$
36,882
   
$
2,047
   
$
35,047
 
Capitalization
   
9,910
     
10,233
     
8,761
     
10,294
 
Amortization
   
(9,590
)
   
(9,803
)
   
(8,829
)
   
(8,459
)
Balance, end of year
 
$
2,299
   
$
37,312
   
$
1,979
   
$
36,882
 

Note 5.
Insurance Reserves and Policyholder Funds

The following table presents the Company’s reserves for life, accident and health, and property and casualty losses, claims and loss adjustment expenses at December 31, 2020 and 2019.

               
Amount of
Insurance In Force, Net
 
   
2020
   
2019
   
2020
   
2019
 
Future policy benefits
                       
Life insurance policies:
                       
Ordinary life and annuities
 
$
54,442
   
$
55,403
   
$
199,827
   
$
212,774
 
Group life
   
91
     
93
     
83,533
(1) 
   
33,508
 
     
54,533
     
55,496
   
$
283,360
   
$
246,282
 
Accident and health insurance policies
   
36,339
     
36,994
                 
     
90,872
     
92,490
                 
Unearned premiums
   
27,131
     
26,035
                 
Losses, claims and loss adjustment expenses
   
79,147
     
81,448
                 
Other policy liabilities
   
1,526
     
1,933
                 
Total insurance reserves and policyholder funds
 
$
198,676
   
$
201,906
                 

(1)
The group life in force amounts increased significantly during 2020. However, the impact on future policy benefits is not significant due to the deferred premium offset to the gross benefit reserve.

Annualized premiums for accident and health insurance policies were $109,430 and $112,734 at December 31, 2020 and 2019, respectively.

Future Policy Benefits

Liabilities for life insurance future policy benefits are based upon assumed future investment yields, mortality rates, and withdrawal rates after giving effect to possible risks of unexpected claim experience. The assumed mortality, withdrawal rates and expenses are based upon the Company’s experience modified as necessary to reflect anticipated trends and are generally established at contract inception.  The interest rates assumed for life, accident and health future policy benefits are generally: (i) 2.5% to 5.5% for issues prior to 1977, (ii) 7% graded to 5.5% for 1977 through 1979 issues, (iii) 9% for 1980 through 1987 issues, (iv) 5% to 7% for 1988 through 2009 issues, (v) 4% for 2010 through 2012 issues, and (vi) 3.5% to 4.0% for 2013 through 2020 issues.

Loss and Claim Reserves

Loss and claim reserves represent estimates of projected ultimate losses and are based upon: (a) management’s estimate of ultimate liability and claims adjusters’ evaluations for unpaid claims reported prior to the close of the accounting period, (b) estimates of IBNR claims based on past experience, and (c) estimates of loss adjustment expenses. The estimated liability is periodically reviewed by management and updated, with changes to the estimated liability recorded in the statement of operations in the year in which such changes are known.

Activity in the liability for unpaid loss and claim reserves is summarized as follows:

   
2020
   
2019
 
Balance at January 1
 
$
81,448
   
$
72,612
 
Less: Reinsurance recoverable on unpaid losses
   
(18,339
)
   
(14,354
)
Net balance at January 1
   
63,109
     
58,258
 
                 
Incurred related to:
               
Current year
   
122,626
     
137,305
 
Prior years
   
(3,480
)(1)
   
(80
)(2)
Total incurred
   
119,146
     
137,225
 
                 
Paid related to:
               
Current year
   
84,518
     
95,489
 
Prior years
   
36,190
     
36,885
 
Total paid
   
120,708
     
132,374
 
Net balance at December 31
   
61,547
     
63,109
 
Plus: Reinsurance recoverable on unpaid losses
   
17,600
     
18,339
 
Balance at December 31
 
$
79,147
   
$
81,448
 

(1)
Prior years’ development was primarily the result of favorable development in the loss and claim reserves for the Medicare supplement line of business in Bankers Fidelity.  Rate increases on existing business and the resultant improvement in rate adequacy was more favorable than expected.  Additionally, the Company experienced favorable development in the surety line of business in American Southern due to a reduction in exposure coupled with recoveries on certain prior year losses.

(2)
Prior years’ development was primarily the result of better than expected development on prior years loss and claim reserves for certain lines of business in American Southern, somewhat offset by unfavorable development on prior years loss and claim reserves for the Medicare Supplement line of business in Bankers Fidelity.

Following is a reconciliation of total incurred losses to total insurance benefits and losses incurred:

   
2020
   
2019
 
Total incurred losses
 
$
119,146
   
$
137,225
 
Cash surrender value and matured endowments
   
1,198
     
1,362
 
Benefit reserve changes
   
(468
)
   
638
 
Total insurance benefits and losses incurred
 
$
119,876
   
$
139,225
 

Liability for Unpaid Losses, Claims and Loss Adjustment Expenses

The following is information, by significant product lines, about incurred and paid claims development as of December 31, 2020, net of reinsurance, as well as the cumulative number of reported claims and the total of IBNR reserves plus expected development on reported claims included within the net incurred claims amounts. The information presented for the years ended December 31, 2015 and prior is presented as supplementary information and is unaudited.

Medicare Supplement

   
For the Years Ended December 31,
   
As of December 31, 2020
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported Claims
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
38,188
   
$
38,296
   
$
38,360
   
$
38,327
   
$
38,316
   
$
38,302
   
$
38,299
   
$
38,297
   
$
38,297
   
$
38,297
   
$
     
664,056
 
2012
           
50,021
     
50,996
     
51,021
     
50,998
     
50,989
     
50,987
     
50,985
     
50,984
     
50,984
     
     
867,050
 
2013
                   
56,974
     
56,970
     
57,034
     
57,023
     
57,021
     
57,016
     
57,015
     
57,014
     
     
957,363
 
2014
                           
57,179
     
56,938
     
56,981
     
56,981
     
56,976
     
56,977
     
56,976
     
     
939,478
 
2015
                                   
55,482
     
54,939
     
54,993
     
54,990
     
54,984
     
54,985
     
     
898,374
 
2016
                                           
58,849
     
59,851
     
63,226
     
63,225
     
63,221
     
     
1,036,769
 
2017
                                                   
67,960
     
69,655
     
69,643
     
69,635
     
     
1,510,654
 
2018
                                                           
79,140
     
80,404
     
80,361
     
     
1,782,982
 
2019
                                                                   
88,765
     
87,028
     
172
     
2,242,156
 
2020
                                                                           
75,857
     
12,728
     
1,620,697
 
                                                                           
$
634,358
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
31,720
   
$
38,296
   
$
38,360
   
$
38,327
   
$
38,316
   
$
38,302
   
$
38,299
   
$
38,297
   
$
38,297
   
$
38,297
 
2012
           
42,267
     
50,996
     
51,021
     
50,998
     
50,989
     
50,987
     
50,985
     
50,984
     
50,984
 
2013
                   
47,770
     
56,970
     
57,034
     
57,023
     
57,021
     
57,016
     
57,015
     
57,014
 
2014
                           
48,024
     
56,938
     
56,981
     
56,981
     
56,976
     
56,977
     
56,976
 
2015
                                   
45,430
     
54,876
     
54,993
     
54,990
     
54,984
     
54,985
 
2016
                                           
49,165
     
59,747
     
63,226
     
63,225
     
63,221
 
2017
                                                   
57,696
     
69,517
     
69,643
     
69,635
 
2018
                                                           
66,565
     
80,222
     
80,361
 
2019
                                                                   
72,333
     
86,856
 
2020
                                                                           
63,129
 
                                                                           
$
621,458
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
12,900
 

The cumulative number of reported claims for the Medicare supplement line of business is the number of distinct claims incurred and submitted to Medicare for payment in the given year. Multiple payments on the same claim are not counted in the frequency information. Estimated ultimate claims incurred, using claims data reported during each month of any given year, are calculated using the chain ladder method modified to use seasonality and trend-adjusted expected claims for the final four months. Additional adjustments to the estimated ultimate claims incurred are then applied to account for seasonal changes in billing and payment frequencies. The IBNR reserve is calculated as estimated ultimate claims less paid claims and claims in course of settlement. Thirty-six months of loss data are used to develop the estimated ultimate incurred claims. Similar approaches are used for other less significant health products, subject to modifications to account for unique aspects of the product.

Automobile Liability

   
For the Years Ended December 31,
   
As of December 31,
2020
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported Claims
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
12,263
   
$
13,802
   
$
13,235
   
$
13,289
   
$
13,281
   
$
13,495
   
$
13,385
   
$
13,330
   
$
13,329
   
$
13,328
   
$
     
2,134
 
2012
           
12,980
     
15,007
     
14,108
     
13,707
     
13,313
     
13,343
     
13,357
     
13,373
     
13,373
     
     
2,343
 
2013
                   
18,664
     
20,702
     
21,096
     
21,823
     
21,352
     
21,020
     
20,972
     
20,972
     
     
3,267
 
2014
                           
20,812
     
21,881
     
22,041
     
22,353
     
21,682
     
22,080
     
22,100
     
48
     
3,544
 
2015
                                   
18,521
     
19,857
     
20,017
     
20,007
     
20,086
     
20,680
     
75
     
3,525
 
2016
                                           
20,549
     
21,275
     
21,846
     
22,388
     
22,245
     
140
     
3,842
 
2017
                                                   
22,179
     
24,212
     
23,766
     
25,180
     
801
     
3,772
 
2018
                                                           
24,284
     
25,682
     
27,338
     
2,072
     
3,578
 
2019
                                                                   
25,241
     
24,045
     
3,117
     
3,479
 
2020
                                                                           
22,416
     
12,187
     
2,183
 
                                                                           
$
211,677
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
4,205
   
$
7,934
   
$
9,858
   
$
12,071
   
$
13,039
   
$
13,106
   
$
13,199
   
$
13,330
   
$
13,329
   
$
13,328
 
2012
           
4,627
     
8,791
     
11,507
     
12,932
     
13,197
     
13,211
     
13,288
     
13,373
     
13,373
 
2013
                   
5,144
     
12,193
     
16,782
     
19,407
     
20,382
     
20,982
     
20,972
     
20,972
 
2014
                           
6,822
     
13,807
     
17,554
     
20,177
     
20,878
     
21,735
     
21,813
 
2015
                                   
6,226
     
11,878
     
14,938
     
17,612
     
19,557
     
20,234
 
2016
                                           
6,796
     
13,141
     
16,397
     
19,613
     
21,408
 
2017
                                                   
7,401
     
16,317
     
20,221
     
22,778
 
2018
                                                           
6,989
     
15,647
     
21,121
 
2019
                                                                   
7,305
     
14,694
 
2020
                                                                           
5,172
 
                                                                           
$
174,893
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
36,784
 

Automobile Physical Damage

   
For the Years Ended December 31,
   
As of December 31, 2020
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses,
Net of Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported
Claims
 
Accident Year
 
2016
   
2017
   
2018
   
2019
   
2020
 
2016
 
$
6,877
   
$
6,386
   
$
6,352
   
$
6,289
   
$
6,289
   
$
     
1,269
 
2017
           
6,257
     
5,933
     
5,857
     
5,860
     
     
1,324
 
2018
                   
7,805
     
7,530
     
7,447
     
     
1,452
 
2019
                           
8,526
     
8,026
     
2
     
1,485
 
2020
                                   
10,288
     
177
     
1,526
 
                                   
$
37,910
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment
Expenses, Net of Reinsurance
 
Accident Year
 
2016
   
2017
   
2018
   
2019
   
2020
 
2016
 
$
5,804
   
$
6,353
   
$
6,349
   
$
6,289
   
$
6,289
 
2017
           
5,215
     
5,914
     
5,856
     
5,860
 
2018
                   
6,344
     
7,510
     
7,446
 
2019
                           
6,360
     
8,005
 
2020
                                   
8,347
 
                                   
$
35,947
 
All outstanding liabilities before 2016, net of reinsurance
     
1
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
1,964
 

General Liability

   
For the Years Ended December 31,
   
As of December 31,
2020
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported Claims
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
3,022
   
$
1,723
   
$
1,452
   
$
1,338
   
$
1,174
   
$
1,242
   
$
1,327
   
$
1,335
   
$
1,400
   
$
1,534
   
$
20
     
210
 
2012
           
4,055
     
1,305
     
1,269
     
1,270
     
1,214
     
1,333
     
1,344
     
1,377
     
1,388
     
25
     
161
 
2013
                   
3,461
     
728
     
926
     
817
     
865
     
820
     
945
     
904
     
11
     
197
 
2014
                           
3,744
     
501
     
557
     
476
     
406
     
497
     
523
     
6
     
194
 
2015
                                   
4,421
     
1,037
     
1,227
     
1,044
     
867
     
855
     
     
146
 
2016
                                           
3,119
     
1,148
     
736
     
608
     
621
     
1
     
92
 
2017
                                                   
1,490
     
488
     
513
     
738
     
68
     
82
 
2018
                                                           
1,656
     
333
     
198
     
40
     
75
 
2019
                                                                   
1,916
     
707
     
261
     
82
 
2020
                                                                           
2,223
     
1,749
     
62
 
                                                                           
$
9,691
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
295
   
$
412
   
$
582
   
$
835
   
$
1,161
   
$
1,169
   
$
1,278
   
$
1,285
   
$
1,325
   
$
1,426
 
2012
           
371
     
707
     
847
     
1,034
     
1,113
     
1,219
     
1,260
     
1,269
     
1,280
 
2013
                   
104
     
339
     
579
     
811
     
791
     
803
     
805
     
855
 
2014
                           
171
     
299
     
331
     
369
     
373
     
493
     
498
 
2015
                                   
98
     
259
     
464
     
664
     
863
     
855
 
2016
                                           
116
     
203
     
568
     
608
     
617
 
2017
                                                   
75
     
136
     
365
     
556
 
2018
                                                           
65
     
90
     
115
 
2019
                                                                   
41
     
209
 
2020
                                                                           
208
 
                                                                           
$
6,619
 
All outstanding liabilities before 2011, net of reinsurance
     
343
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
3,415
 

Surety

   
For the Years Ended December 31,
   
As of December 31, 2020
 
   
Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of
Reinsurance
   
IBNR
Reserves
   
Cumulative
Number of
Reported Claims
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
4,422
   
$
4,786
   
$
5,080
   
$
5,092
   
$
4,966
   
$
5,031
   
$
5,112
   
$
5,111
   
$
5,112
   
$
5,163
   
$
7
     
128
 
2012
           
4,979
     
4,767
     
5,396
     
5,345
     
4,869
     
4,880
     
4,892
     
4,925
     
4,944
     
2
     
89
 
2013
                   
3,060
     
2,007
     
2,743
     
2,947
     
2,866
     
2,809
     
2,765
     
2,757
     
     
58
 
2014
                           
3,214
     
3,130
     
2,990
     
2,760
     
2,685
     
2,617
     
2,818
     
43
     
54
 
2015
                                   
1,902
     
1,630
     
1,400
     
1,359
     
1,406
     
1,310
     
6
     
50
 
2016
                                           
3,314
     
1,812
     
1,865
     
1,876
     
1,865
     
     
46
 
2017
                                                   
4,677
     
3,671
     
3,799
     
3,629
     
13
     
58
 
2018
                                                           
3,528
     
1,938
     
1,381
     
6
     
62
 
2019
                                                                   
2,130
     
657
     
128
     
30
 
2020
                                                                           
2,263
     
1,887
     
20
 
                                                                           
$
26,787
                 

   
Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance
 
Accident Year
 
2011
   
2012
   
2013
   
2014
   
2015
   
2016
   
2017
   
2018
   
2019
   
2020
 
2011
 
$
1,031
   
$
3,207
   
$
4,622
   
$
4,748
   
$
4,939
   
$
5,022
   
$
5,109
   
$
5,111
   
$
5,112
   
$
5,117
 
2012
           
2,257
     
4,581
     
4,856
     
5,331
     
4,869
     
4,880
     
4,878
     
4,916
     
4,934
 
2013
                   
323
     
1,010
     
1,369
     
2,763
     
2,789
     
2,749
     
2,765
     
2,757
 
2014
                           
1,331
     
2,327
     
2,727
     
2,739
     
2,664
     
2,593
     
2,562
 
2015
                                   
641
     
856
     
1,127
     
1,125
     
1,128
     
1,271
 
2016
                                           
1,054
     
1,732
     
1,772
     
1,873
     
1,862
 
2017
                                                   
1,971
     
3,255
     
3,523
     
3,545
 
2018
                                                           
1,157
     
1,454
     
1,361
 
2019
                                                                   
259
     
395
 
2020
                                                                           
97
 
                                                                           
$
23,901
 
All outstanding liabilities before 2011, net of reinsurance
     
54
 
Liabilities for losses, claims and loss adjustment expenses, net of reinsurance
   
$
2,940
 

For the property and casualty lines of business, the number of claims presented above equals the number of occurrences by type of claim reported to the Company. The number of claims reported during a given year corresponds to the number of claims records opened during the year. Frequency information is maintained on a cumulative basis by accident year by line of business. For automobile claims, a claim count is separately maintained for bodily injury, property damage and physical damage claims. The Company has consistently monitored claim frequency on this basis, and believes this provides more meaningful information than using claimant count which can change over the course of settling a claim.

In general, when a claim is reported, claims representatives establish a “case reserve” for the estimated amount of the ultimate payment based on the known information of the claim at that time. Claims managers review and monitor all property and casualty claims in excess of $25,000. As new information becomes available or payments are made on a claim, the case reserve is adjusted to reflect the revised estimate of the ultimate amount to be paid out. Estimates and assumptions pertaining to individual claims are based on complex and subjective judgments and subject to change at any time as new information becomes available.

In addition to case reserves, IBNR reserves are established to provide for claims which have not been reported to the Company as of the reporting date as well as potential adverse development on known case reserves. IBNR reserve estimates are derived through a number of analytical techniques. Actuarial data is analyzed by line of business, coverage and accident year. Qualitative factors are also considered in determining IBNR reserves and include such factors as judicial decisions, general economic trends such as inflation, changes in policy forms, and underwriting changes. Reserves are reviewed quarterly and any indicated adjustments are made.

Because of the inherent uncertainties in establishing both case and IBNR reserves, ultimate loss experience may prove better or worse than indicated by the combined claim reserves. Adjustments to claim reserves are reflected in the period recognized and could increase or decrease earnings for the period.

The following is supplementary information about average historical claims duration as of December 31, 2020.

   
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Unaudited)
 
Reserve Line
 
1st Year
   
2nd Year
   
3rd Year
   
4th Year
   
5th Year
   
6th Year
   
7th Year
   
8th Year
   
9th Year
   
10th Year
 
Medicare Supplement
   
83.0
%
   
16.9
%
   
0.1
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
Automobile Liability
   
29.1
%
   
30.9
%
   
17.3
%
   
12.7
%
   
5.8
%
   
2.1
%
   
0.4
%
   
0.5
%
   
0.0
%
   
0.0
%
Automobile Physical Damage
   
85.4
%
   
14.2
%
   
-0.6
%
   
-0.4
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
   
0.0
%
General Liability
   
17.8
%
   
17.8
%
   
22.5
%
   
16.9
%
   
8.4
%
   
6.3
%
   
2.8
%
   
2.2
%
   
1.7
%
   
6.6
%
Surety
   
41.2
%
   
31.1
%
   
10.5
%
   
9.8
%
   
-1.3
%
   
1.8
%
   
0.3
%
   
0.2
%
   
0.2
%
   
0.1
%

The reconciliation of the net incurred and paid claims development tables to the liability for losses, claims and loss adjustment expenses is as follows:

   
December 31, 2020
 
Net outstanding liabilities
     
Medicare Supplement
 
$
12,900
 
Automobile Liability
   
36,784
 
Automobile Physical Damage
   
1,964
 
General Liability
   
3,415
 
Surety
   
2,940
 
Other short-duration insurance lines
   
1,666
 
Liabilities for unpaid losses, claims and loss adjustment expenses, net of reinsurance
   
59,669
 
         
Reinsurance recoverable on unpaid losses:
       
Medicare Supplement
   
8,975
 
Automobile Liability
   
6,260
 
Automobile Physical Damage
   
3
 
General Liability
   
2,362
 
Total reinsurance recoverable on unpaid losses
   
17,600
 
         
Unallocated claims adjustment expenses
   
1,878
 
         
Total gross liability for unpaid losses, claims and loss adjustment expenses
 
$
79,147
 

Note 6.
Reinsurance

In accordance with general practice in the insurance industry, portions of the life, property and casualty insurance written by the Company are reinsured; however, the Company remains liable with respect to reinsurance ceded should any reinsurer be unable or unwilling to meet its obligations. Approximately 99.6% of the Company’s reinsurance recoverables were due from a single reinsurer as of December 31, 2020. Reinsurance recoverables of $28,980 were due from General Re Corporation, rated “AA+” by Standard & Poor’s and “A++” (Superior) by A.M. Best. Allowances for uncollectible amounts are established against reinsurance recoverables, if appropriate.

The effects of reinsurance on premiums written, premiums earned and insurance benefits and losses incurred were as follows:

   
2020
   
2019
 
Direct premiums written
 
$
239,687
   
$
237,973
 
Assumed premiums written
   
23,253
     
23,275
 
Ceded premiums written
   
(77,622
)
   
(77,750
)
Net premiums written
 
$
185,318
   
$
183,498
 
                 
Direct premiums earned
 
$
238,209
   
$
237,361
 
Assumed premiums earned
   
23,144
     
22,345
 
Ceded premiums earned
   
(77,814
)
   
(77,781
)
Net premiums earned
 
$
183,539
   
$
181,925
 
                 
Provision for benefits and losses incurred
 
$
175,825
   
$
206,390
 
Reinsurance loss recoveries
   
(55,949
)
   
(67,165
)
Insurance benefits and losses incurred
 
$
119,876
   
$
139,225
 

Components of reinsurance receivables at December 31, 2020 and 2019 were as follows:

   
2020
   
2019
 
Recoverable on unpaid losses
 
$
17,600
   
$
18,339
 
Recoverable on unpaid benefits
   
9,832
     
10,772
 
Recoverable on paid losses
   
447
     
1,538
 
Ceded unearned premiums
   
963
     
1,155
 
Ceded advanced premiums
   
244
     
331
 
Total reinsurance receivables
 
$
29,086
   
$
32,135
 

Note 7.
Income Taxes

Total income taxes were allocated as follows:

   
2020
   
2019
 
Total tax expense (benefit) on income
 
$
3,334
   
$
(21
)
                 
Tax expense on components of shareholders’ equity:
               
Net unrealized gains on investment securities
   
3,865
     
4,783
 
Total tax expense
 
$
7,199
   
$
4,762
 

A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and the income tax benefit is as follows:

   
2020
   
2019
 
Federal income tax provision
 
$
3,256
   
$
(86
)
Statutory rate
   
21
%
   
21
%
Dividends-received deduction
   
(12
)
   
(23
)
Meals & entertainment
   
20
     
55
 
Vested stock & club dues
   
36
     
37
 
Parking disallowance
   
16
     
17
 
Adjustment for prior years’ estimates to actual
   
18
     
(21
)
Income tax expense (benefit)
 
$
3,334
   
$
(21
)
Effective tax rate
   
21.5
%
   
5.2
%

The primary differences between the effective tax rate and the federal statutory income tax rate for 2020 resulted from permanent differences related to meals & entertainment and vested stock grants.  Also contributing to differences between the effective tax rate and the federal statutory income tax rate were provision-to-filed return adjustments that are generally updated at the completion of the third quarter of each fiscal year and were $18 in the year ended December 31, 2020.

The primary differences between the effective tax rate and the federal statutory income tax rate for 2019 resulted from permanent differences related to meals & entertainment and vested stock grants. Also contributing to differences between the effective tax rate and the federal statutory income tax rate was the dividends-received deduction (“DRD”). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from investments as well as the amount of the Company’s taxable income.

Deferred tax assets and liabilities at December 31, 2020 and 2019 were comprised of the following:

   
2020
   
2019
 
Deferred tax assets:
           
Deferred acquisition costs
 
$
4,666
   
$
2,540
 
Insurance reserves
   
2,682
     
3,323
 
Impaired assets
   
822
     
822
 
Bad debts and other
   
326
     
319
 
Total deferred tax assets
   
8,496
     
7,004
 
Deferred tax liabilities:
               
Deferred and uncollected premiums
 
$
(409
)
 
$
(328
)
Net unrealized investment gains
   
(9,235
)
   
(6,090
)
Other
   
(153
)
   
(272
)
Total deferred tax liabilities
   
(9,797
)
   
(6,690
)
Net deferred tax (liability) asset
 
$
(1,301
)
 
$
314
 

The components of income tax expense (benefit) were:

   
2020
   
2019
 
Current – Federal
 
$
5,584
   
$
892
 
Deferred – Federal
   
(2,250
)
   
(913
)
Total
 
$
3,334
   
$
(21
)

The Company has formal tax-sharing agreements, and files a consolidated income tax return, with its subsidiaries. Tax years 2017, 2018 and 2019 are considered open tax years that remain subject to examination by the Internal Revenue Service.

Note 8.
Junior Subordinated Debentures

The Company has two unconsolidated Connecticut statutory business trusts, which exist for the exclusive purposes of: (i) issuing trust preferred securities (“Trust Preferred Securities”) representing undivided beneficial interests in the assets of the trusts; (ii) investing the gross proceeds of the Trust Preferred Securities in junior subordinated deferrable interest debentures (“Junior Subordinated Debentures”) of Atlantic American; and (iii) engaging in those activities necessary or incidental thereto. At December 31, 2020, the effective interest rate was 4.28%.

The financial structure of each of Atlantic American Statutory Trust I and II, as of December 31, 2020 and 2019, was as follows:

   
Atlantic American
Statutory Trust I
   
Atlantic American
Statutory Trust II
 
JUNIOR SUBORDINATED DEBENTURES(1)(2)
           
Balance December 31, 2020
 
$
18,042
   
$
23,196
 
Less: Treasury debt(3)
   
     
(7,500
)
Net balance December 31, 2020
 
$
18,042
   
$
15,696
 
Net balance December 31, 2019
 
$
18,042
   
$
15,696
 
Coupon rate
 
LIBOR + 4.00%
   
LIBOR + 4.10%
 
Interest payable
 
Quarterly
   
Quarterly
 
Maturity date
 
December 4, 2032
   
May 15, 2033
 
Redeemable by issuer
 
Yes
   
Yes
 
TRUST PREFERRED SECURITIES
               
Issuance date
 
December 4, 2002
   
May 15, 2003
 
Securities issued
   
17,500
     
22,500
 
Liquidation preference per security
 
$
1
   
$
1
 
Liquidation value
 
$
17,500
   
$
22,500
 
Coupon rate
 
LIBOR + 4.00%
   
LIBOR + 4.10%
 
Distribution payable
 
Quarterly
   
Quarterly
 
Distribution guaranteed by(4)
 
Atlantic American Corporation
   
Atlantic American Corporation
 

(1)
For each of the respective debentures, the Company has the right at any time, and from time to time, to defer payments of interest on the Junior Subordinated Debentures for a period not exceeding 20 consecutive quarters up to the debentures’ respective maturity dates. During any such period, interest will continue to accrue and the Company may not declare or pay any cash dividends or distributions on, or purchase, the Company’s common stock nor make any principal, interest or premium payments on or repurchase any debt securities that rank equally with or junior to the Junior Subordinated Debentures. The Company has the right at any time to dissolve each of the trusts and cause the Junior Subordinated Debentures to be distributed to the holders of the Trust Preferred Securities.
(2)
The Junior Subordinated Debentures are unsecured and rank junior and subordinate in right of payment to all senior debt of the Parent and are effectively subordinated to all existing and future liabilities of its subsidiaries.
(3)
In 2014, the Company acquired $7,500 of the Junior Subordinated Debentures.
(4)
The Parent has guaranteed, on a subordinated basis, all of the obligations under the Trust Preferred Securities, including payment of the redemption price and any accumulated and unpaid distributions to the extent of available funds and upon dissolution, winding up or liquidation.

Note 9.
Leases

The Company has two operating lease agreements, each for the use of office space in the ordinary course of business. The first lease renews annually on an automatic basis and based on original assumptions, management is reasonably certain to exercise the renewal option through 2026. The original term of the second lease was ten years and amended in January 2017 to provide for an additional seven years, with a termination date on September 30, 2026. The rate used in determining the present value of lease payments is based upon an estimate of the Company’s incremental secured borrowing rate commensurate with the term of the underlying lease.

These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Lease expense reported for each of the years ended December 31, 2020 and 2019 was $1,014.

Additional information regarding the Company’s real estate operating leases is as follows:

   
Year Ended
December 31, 2020
   
Year Ended December 31, 2019
 
Other information on operating leases:
           
Cash payments included in the measurement of lease liabilities reported in operating cash flows
 
$
978
     
815
 
Right-of-use assets included in other assets on the consolidated balance sheet
   
4,832
     
5,476
 
Weighted average discount rate
   
6.8
%
   
6.8
%
Weighted average remaining lease term in years
 
5.9 years
   
6.9 years
 

The following table presents maturities and present value of the Company’s lease liabilities:

   
Lease Liability
 
2021
 
$
1,015
 
2022
   
1,031
 
2023
   
1,048
 
2024
   
1,065
 
2025
   
1,083
 
Thereafter
   
942
 
Total undiscounted lease payments
   
6,184
 
Less: present value adjustment
   
1,116
 
Operating lease liability included in accounts payable and accrued expenses on the consolidated balance sheet
 
$
5,068
 

As of December 31, 2020, the Company has no operating leases that have not yet commenced.

 Note 10.
Benefit Plans

Equity Incentive Plan

On May 1, 2012, the Company’s shareholders approved the 2012 Equity Incentive Plan (the “2012 Plan”). The 2012 Plan authorizes the grant of up to 2,000,000 stock options, stock appreciation rights, restricted shares, restricted stock units, performance shares, performance units and other awards for the purpose of providing the Company’s non-employee directors, consultants, officers and other employees incentives and rewards for superior performance. In 2020, a total of 20,000 restricted shares, with an estimated fair value of $38, were issued under the 2012 Plan and 35,000 restricted shares, with an estimated fair value of $98, were forfeited under such plan. In 2019, a total of 355,000 restricted shares, with an estimated fair value of $948, were issued under the 2012 Plan. The estimated fair value of the restricted shares issued under the 2012 Plan for 2020 and 2019 was based on the common stock price at date of grant. Stock grants are generally issued from treasury shares. Vesting of restricted shares generally occurs after a one to three year period. The Company accounts for forfeitures as they occur. There were no stock options granted or outstanding under the 2012 Plan in 2020 or 2019. Shares available for future grant at December 31, 2020 and 2019 were 935,200 and 920,200, respectively.

401(k) Plan

The Company initiated an employees’ savings plan (the “Plan”) qualified under Section 401(k) of the Internal Revenue Code in May 1995. The Plan covers substantially all of the Company’s employees. Effective January 1, 2009, the Company modified the Plan such that the Plan would operate on a safe harbor basis. Under the Plan, employees may defer up to 50% of their compensation, not to exceed the annual deferral limit. The Company’s total matching contribution for 2020 and 2019 was $231 and $230, respectively, and consisted of a contribution equal to 35% of up to the first 6% of each participant’s contributions. In addition to the matching contribution, the Company also provided a 3% safe harbor non-elective contribution in 2020 and 2019 of $520 and $524, respectively. All contributions were made in cash. Participants are 100% vested in their own contributions and the vested percentage attributable to certain employer contributions is based on a five-year graded schedule.

Agent Stock Purchase Plan

The Company initiated a nonqualified stock purchase plan (the “Agent Stock Purchase Plan”) in May 2012. The purpose of the Agent Stock Purchase Plan is to promote and advance the interests of the Company and its shareholders by providing independent agents who qualify as participants with an opportunity to purchase the common stock of the Company. Under the Agent Stock Purchase Plan, payment for shares of common stock of the Company is made by either deduction from an agent’s commission payment or a direct cash payment. Stock purchases are made at the end of each calendar quarter at the then current market value.

 Note 11.
Preferred Stock

The Company had 55,000 shares of Series D preferred stock (“Series D Preferred Stock”) outstanding at December 31, 2020 and 2019, respectively. All of the shares of Series D Preferred Stock are held by an affiliate of the Company’s controlling shareholder. The outstanding shares of Series D Preferred Stock have a par value of $1 per share and a redemption value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company’s common stock at the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company’s common stock, subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company’s option. The Series D Preferred Stock is not currently convertible. The Company had accrued, but unpaid, dividends, on the Series D Preferred Stock of $18 at December 31, 2020 and 2019. During each of 2020 and 2019, the Company paid Series D Preferred Stock dividends of $399.

Note 12.
Earnings (Loss) Per Common Share

Basic earnings per share was computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. The computation of diluted earnings per share reflected the effect of potentially dilutive securities.

A reconciliation of the numerator and denominator of the income (loss) per common share calculations is as follows:

   
For the Year Ended December 31, 2020
 
   
Income
   
Weighted
Average Shares
Outstanding
(In thousands)
   
Per Share
Amount
 
Basic Earnings Per Common Share
                 
Net income before preferred stock dividends
 
$
12,169
     
20,441
     
-
 
Less preferred stock dividends
   
(399
)
   
         
   Net income applicable to common shareholders
   
11,770
     
20,441
     
0.58
 
Diluted Earnings Per Common Share:
                       
Effect of Series D preferred stock
   
399
     
1,378
         
Net income applicable to common shareholders
 
$
12,169
     
21,819
   
$
0.56
 

   
For the Year Ended December 31, 2019
 
   
Loss
   
Weighted
Average Shares
Outstanding
(In thousands)
   
Per Share
Amount
 
Basic and Diluted Loss Per Common Share
                 
Net loss before preferred stock dividends
 
$
(386
)
   
20,258
     
-
 
Less preferred stock dividends
   
(399
)
   
         
Net loss applicable to common shareholders
 
$
(785
)
   
20,258
   
$
(.04
)

The assumed conversion of the Company’s Series D Preferred Stock was excluded from the earnings per common share calculation for 2019 since its impact would have been antidilutive.

 Note 13.
Statutory Reporting

The assets, liabilities and results of operations have been reported on the basis of GAAP, which varies in some respects from statutory accounting practices (“SAP”) prescribed or permitted by insurance regulatory authorities. The principal differences between SAP and GAAP are that under SAP: (i) certain assets that are non-admitted assets are eliminated from the balance sheet; (ii) acquisition costs for policies are expensed as incurred, while they are deferred and amortized over the estimated life of the policies under GAAP; (iii) the provision that is made for deferred income taxes is different than under GAAP; (iv) the timing of establishing certain reserves is different than under GAAP; and (v) certain valuation allowances attributable to certain investments are different.

The Company meets the minimum capital requirements in the states in which it does business. The amount of reported statutory net income and surplus (shareholders’ equity) for the Parent’s insurance subsidiaries for the years ended December 31 was as follows:

   
2020
   
2019
 
Bankers Fidelity, net income (loss)
 
$
7,712
   
$
(9,509
)
American Southern, net income
   
8,575
     
4,778
 
Statutory net income (loss)
 
$
16,287
   
$
(4,731
)
                 
Bankers Fidelity, surplus
 
$
42,326
   
$
35,546
 
American Southern, surplus
   
50,194
     
45,827
 
Statutory surplus
 
$
92,520
   
$
81,373
 

Under the insurance code of the state in which each insurance subsidiary is domiciled, dividend payments to the Parent by its insurance subsidiaries are subject to certain limitations without the prior approval of the applicable state’s Insurance Commissioner. The Parent received dividends of $3,900 and $4,800 in the years ended 2020 and 2019, respectively, from its subsidiaries. In 2020, dividend payments to the Parent by the insurance subsidiaries in excess of $9,589 would require prior approval.

 Note 14.
Related Party Transactions

In the normal course of business the Company has engaged in transactions with entities affiliated with the controlling shareholder of the Company. These transactions include the leasing of office space as well as certain investing and financing activities. At December 31, 2020, two members of the Company’s board of directors, including the Company’s chairman, president and chief executive officer, were considered to be affiliates of the majority shareholder.

The Company leases approximately 49,586 square feet of office and covered garage space from one such controlled entity. During the years ended December 31, 2020 and 2019, the Company paid $939 and $908, respectively, under this lease.

Certain financing for the Company has also been provided by this entity in the form of an investment in the Series D Preferred Stock (See Note 11). During the years ended December 31, 2020 and 2019, the Company paid this entity $399 in dividends on the Series D Preferred Stock.

Certain members of the Company’s management and board of directors are shareholders and on the board of directors of Gray Television, Inc. (“Gray”). As of December 31, 2020 and 2019, the Company owned 880,272 shares of Gray Class A common stock and 106,000 shares of Gray common stock. The aggregate carrying value of these investments in Gray at December 31, 2020 and 2019 was $16,606 and $19,764, respectively.

During the years ended December 31, 2020 and 2019, Gray paid the Company approximately $1,038 and $1,022, respectively, in insurance premiums related to certain voluntary employee benefit plans.

During the year ended December 31, 2019, the Company transferred its remaining fractional interest in an aircraft arrangement to Gray for $151.

Note 15.
Segment Information

The Parent’s primary insurance subsidiaries operate with relative autonomy and each company is evaluated based on its individual performance. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each segment derives revenue from the collection of premiums, as well as from investment income. Substantially all revenue other than that in the corporate and other segment is from external sources.

   
For the Year Ended December 31, 2020
 
   
American
Southern
   
Bankers
Fidelity
   
Corporate
& Other
   
Adjustments
& Eliminations
   
Consolidated
 
Insurance premiums, net
 
$
62,372
   
$
121,167
   
$
   
$
   
$
183,539
 
Insurance benefits and losses incurred
   
39,339
     
80,537
     
     
     
119,876
 
Expenses deferred
   
(9,910
)
   
(10,233
)
   
     
     
(20,143
)
Amortization and depreciation expense
   
9,772
     
10,007
     
594
     
     
20,373
 
Other expenses
   
19,542
     
34,403
     
14,526
     
(8,732
)
   
59,739
 
Total expenses
   
58,743
     
114,714
     
15,120
     
(8,732
)
   
179,845
 
Underwriting income
   
3,629
     
6,453
     
-

    -
      10,082
 
Net investment income
   
3,586
     
4,971
     
1,174
     
(1,987
)
   
7,744
 
Other income
   
37
     
11
     
6,773
     
(6,745
)
   
76
 
Operating income (loss)
   
7,252
     
11,435
     
(7,173
)
   
     
11,514
 
Net realized gains
   
3,389
     
4,031
     
     
     
7,420
 
Unrealized losses on equity securities
   
(205
)
   
(3,036
)
   
(190
)
   
     
(3,431
)
Income (loss) before income taxes
 
$
10,436
   
$
12,430
   
$
(7,363
)
 
$
   
$
15,503
 
Total revenues
 
$
69,179
   
$
127,144
   
$
7,757
   
$
(8,732
)
 
$
195,348
 
Intangibles
 
$
1,350
   
$
1,194
   
$
   
$
   
$
2,544
 
Total assets
 
$
158,808
   
$
236,197
   
$
183,178
   
$
(172,996
)
 
$
405,187
 

   
For the Year Ended December 31, 2019
 
   
American
Southern
   
Bankers
Fidelity
   
Corporate
& Other
   
Adjustments
& Eliminations
   
Consolidated
 
Insurance premiums, net
 
$
58,680
   
$
123,245
   
$
   
$
   
$
181,925
 
Insurance benefits and losses incurred
   
39,541
     
99,684
     
     
     
139,225
 
Expenses deferred
   
(8,761
)
   
(10,294
)
   
     
     
(19,055
)
Amortization and depreciation expense
   
9,024
     
8,709
     
551
     
     
18,284
 
Other expenses
   
16,869
     
37,158
     
15,939
     
(9,834
)
   
60,132
 
Total expenses
   
56,673
     
135,257
     
16,490
     
(9,834
)
   
198,586
 
Underwriting income (loss)
   
2,007
     
(12,012
)
   
-

    -
      (10,005
)
Net investment income
   
3,689
     
5,317
     
2,597
     
(2,624
)
   
8,979
 
Other income
   
75
     
18
     
7,307
     
(7,210
)
   
190
 
Operating income (loss)
   
5,771
     
(6,677
)
   
(6,586
)
   
     
(7,492
)
Net realized gains (losses)
   
(386
)
   
840
     
1,120
     
     
1,574
 
Unrealized gains on equity securities
   
344
     
2,191
     
2,976
     
     
5,511
 
Income (loss) before income taxes
 
$
5,729
   
$
(3,646
)
 
$
(2,490
)
 
$
   
$
(407
)
Total revenues
 
$
62,402
   
$
131,611
   
$
14,000
   
$
(9,834
)
 
$
198,179
 
Intangibles
 
$
1,350
   
$
1,194
   
$
   
$
   
$
2,544
 
Total assets
 
$
141,524
   
$
224,122
   
$
154,687
   
$
(142,707
)
 
$
377,626
 

Note 16.
Commitments and Contingencies

Litigation

From time to time, the Company is, and expects to continue to be, involved in various claims and lawsuits incidental to and in the ordinary course of its business. In the opinion of management, any such known claims are not expected to have a material effect on the financial condition or results of operations of the Company.

Note 17.
Subsequent Events

On March 23, 2021, the Company’s board of directors declared an annual cash dividend of $0.02 per share of common stock that is payable to shareholders of record as of the close of business on April 13, 2021.

Since December 31, 2020, the COVID-19 pandemic continues to cause material disruption to financial markets and the economy.  As a result of the pandemic, the Company could experience future losses in its investment portfolio as a result of the weakened and volatile markets.  Additionally, the Company can experience increased risk of loss any time unforeseen infectious diseases impact large portions of a population. Specifically, the Company’s life and health business could experience significant loss due to increased claims volume arising from COVID-19. The duration and impact of the COVID-19 pandemic is unknown at this time and it is not possible to reliably estimate the impact on the financial condition, operating results or liquidity of the Company and its operating subsidiaries in future periods.

Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.
Controls and Procedures

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, management, including the Chief Executive Officer and Chief Financial Officer, concluded that disclosure controls and procedures were effective as of that date.

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. The Company’s internal control over financial reporting system has been designed to provide reasonable assurance regarding the reliability and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Management recognizes that there are inherent limitations in the effectiveness of any internal control system. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Furthermore, the application of any evaluations of effectiveness on future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2020 based upon the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in the updated 2013 Internal Control – Integrated Framework. Based on that evaluation, management believes that internal control over financial reporting as such term is defined in Exchange Act Rule 13a-15(f) was effective as of December 31, 2020.

There were no changes in our internal control over financial reporting that occurred during the fourth quarter of 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

This Annual Report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to certain rules of the Securities and Exchange Commission that exempt smaller reporting companies, including the Company, from such requirement.

Item 9B.
Other Information

None.

PART III

With the exception of certain information relating to the executive officers of the Company, which is provided in Part I hereof, the information relating to securities authorized for issuance under equity compensation plans and the information relating to the Company’s Code of Business Conduct and Ethics, each of which is included below, all information required by Part III (Items 10, 11, 12, 13 and 14 of Form 10-K) is incorporated by reference to the sections entitled “Election of Directors,” “Security Ownership of Certain Beneficial Owners and Management,” “Delinquent Section 16(a) Reports” (if applicable), “Executive Compensation,” “Certain Relationships and Related Transactions” and “Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm” to be contained in the Company’s definitive proxy statement in connection with the Company’s Annual Meeting of Shareholders to be held on or around May 18, 2021, to be filed with the SEC within 120 days of the Company’s fiscal year end.

Equity Compensation Plan Information

The following table sets forth, as of December 31, 2020, the number of securities issuable upon exercise of outstanding options, warrants and rights, the weighted average exercise price thereof and the number of securities remaining available for future issuance under the Company’s equity compensation plans:

Plan Category
 
Number of
Securities to Be
Issued Upon
Exercise of
Outstanding
Options,
Warrants
and Rights
   
Weighted-Average
Exercise Price
of Outstanding
Options,
Warrants
and Rights
   
Number of Securities
Remaining Available
for Future Issuance
Under Equity
Compensation Plans
(Excluding Securities
Reflected in the
First Column)
 
Equity compensation plans approved by security holders
   
   
$
     
935,200
 
Equity compensation plans not approved by security holders(1)
   
     
     
 
Total
   
   
$
     
935,200
 

(1)
All the Company’s equity compensation plans have been approved by the Company’s shareholders.

The Company has adopted a Code of Business Conduct and Ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or any persons performing similar functions, as well as its directors and other employees. A copy of this Code of Business Conduct and Ethics has been filed as an exhibit to this annual report on Form 10-K.

PART IV

Item 15.
Exhibits and Financial Statement Schedules
 
(a)
List of documents filed as part of this report:

 
1.
Financial Statements:

See Index to Financial Statements contained in Item 8 hereof.


2.
Financial Statement Schedules:

Schedule II - Condensed financial information of the registrant
Schedule III - Supplementary insurance information of the registrant
Schedule IV - Reinsurance information for the registrant
Schedule VI - Supplemental information concerning property-casualty insurance operations of the registrant

Schedules other than those listed above are omitted as they are not required or are not applicable, or the required information is shown in the financial statements or notes thereto. Columns omitted from schedules filed have been omitted because the information is not applicable.


 3.
Exhibits *:

 
Restated Articles of Incorporation of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 10-K for the year ended December 31, 2008].
 
Restated Bylaws of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K filed on March 4, 2016].
 
Description of the registrant’s common stock registered pursuant to section 12 of the Securities Exchange Act of 1934 [incorporated by reference to Exhibit 4.1 to the registrant’s Form 10-K filed on March 24, 2020].
10.01
 
Management Agreement, dated July 1, 1993, between the registrant and Atlantic American Life Insurance Company and Bankers Fidelity Life Insurance Company [incorporated by reference to Exhibit 10.41 to the registrant’s Form 10-Q for the quarter ended September 30, 1993].
 
Tax Allocation Agreement, dated as of January 4, 2016, between the registrant and the registrant’s subsidiaries [incorporated by reference to Exhibit 10.02 to the registrant’s Form 10-K for the year ended December 31, 2017].
 
Atlantic American Corporation 2012 Nonqualified Stock Purchase Plan [incorporated by reference to Exhibit 99.1 to the registrant’s Form S-8 (File No. 333-183207) filed on August 10, 2012].
 
Atlantic American Corporation 2012 Equity Incentive Plan [incorporated by reference to Exhibit 10.1 to the registrant’s Form 10-Q for the quarter ended March 31, 2013].
 
Lease Agreement, dated as of November 1, 2007, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life Insurance Company [incorporated by reference to Exhibit 10.10 to the registrant’s Form 10-K for the year ended December 31, 2007].
 
First Amendment to Lease Agreement, dated as of March 31, 2008, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life Insurance Company [incorporated by reference to Exhibit 10.2 to the registrant’s Form 10-Q for the quarter ended March 31, 2008].
 
Employment and Transition Agreement with Fixed Determination Date, dated as of June 14, 2017 by and between John G. Sample, Jr. and the registrant [incorporated by reference to Exhibit 10.07 to the registrant’s Form 10-K for the year ended December 31, 2017].
 
Code of Business Conduct and Ethics [incorporated by reference to Exhibit 14.1 to the registrant’s Form 10-K for the year ended December 31, 2003].
 
Subsidiaries of the registrant [incorporated by reference to Exhibit 21.1 to the registrant’s Form 10-K for the year ended December 31, 2015].
 
Consent of Dixon Hughes Goodman LLP, Independent Registered Public Accounting Firm.
 
Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
 
XBRL Instance Document.
101.SCH
 
XBRL Taxonomy Extension Schema.
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase.
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase.
101.LAB
 
XBRL Taxonomy Extension Label Linkbase.
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase.

*
The registrant agrees to furnish to the Commission upon request a copy of any instruments defining the rights of security holders of the registrant that may be omitted from filing in accordance with the Commission’s rules and regulations.

**
Management contract, compensatory plan or arrangement required to be filed pursuant to Part IV, Item 15(c) of Form 10-K and Item 601 of Regulation S-K.

Item 16.
Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   
ATLANTIC AMERICAN CORPORATION
   
(Registrant)
     
 
By:
/s/ J. Ross Franklin
   
J. Ross Franklin
   
Vice President and Chief Financial Officer
     
   
Date: March 23, 2021

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature
 
Title
 
Date
         
/s/ Hilton H. Howell, Jr.
 
President, Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
 
March 23, 2021
HILTON H. HOWELL, JR.
   
         
/s/ J. Ross Franklin
 
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
 
March 23, 2021
J. ROSS FRANKLIN
   
         
/s/ Robin R. Howell
 
Director
 
March 23, 2021
ROBIN R. HOWELL
   
         
/s/ Mark E. Preisinger
 
Director
 
March 23, 2021
MARK E. PREISINGER
   
         
/s/ Joseph M. Scheerer
 
Director
 
March 23, 2021
JOSEPH M. SCHEERER
     
         
/s/ Scott G. Thompson
 
Director
 
March 23, 2021
SCOTT G. THOMPSON
   
         
/s/ D. Keehln Wheeler
 
Director
 
March 23, 2021
D. KEEHLN WHEELER
   

Schedule II
Page 1 of 3
CONDENSED FINANCIAL INFORMATION OF REGISTRANT

ATLANTIC AMERICAN CORPORATION
(Parent Company Only)

BALANCE SHEETS

ASSETS

   
December 31,
 
   
2020
   
2019
 
   
(In thousands)
 
Cash and cash equivalents
 
$
2,090
   
$
2,068
 
Investments
   
2,598
     
3,267
 
Investment in subsidiaries
   
172,996
     
142,707
 
Investments in unconsolidated trusts
   
1,238
     
1,238
 
Income taxes receivable from subsidiaries
   
1,683
     
2,304
 
Other assets
   
4,311
     
5,126
 
Total assets
 
$
184,916
   
$
156,710
 
                 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
                 
Deferred tax liability, net
 
$
1,765
   
$
346
 
Other payables
   
4,353
     
4,232
 
Junior subordinated debentures
   
33,738
     
33,738
 
Total liabilities
   
39,856
     
38,316
 
                 
Shareholders’ equity
   
145,060
     
118,394
 
Total liabilities and shareholders’ equity
 
$
184,916
   
$
156,710
 

See accompanying report of independent registered public accounting firm.

Schedule II
Page 2 of 3

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

ATLANTIC AMERICAN CORPORATION
(Parent Company Only)

STATEMENTS OF OPERATIONS

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(In thousands)
 
REVENUE
           
Fee income from subsidiaries
 
$
6,745
   
$
7,210
 
Distributed earnings from subsidiaries
   
3,900
     
4,800
 
Unrealized gains (losses) on equity securities, net
   
(191
)
   
2,976
 
Other
   
(784
)
   
1,190
 
Total revenue
   
9,670
     
16,176
 
                 
GENERAL AND ADMINISTRATIVE EXPENSES
   
11,521
     
11,731
 
                 
INTEREST EXPENSE
   
1,610
     
2,130
 
     
(3,461
)
   
2,315
 
INCOME TAX BENEFIT(1)
   
(3,623
)
   
(2,035
)
     
162
     
4,350
 
EQUITY IN UNDISTRIBUTED EARNINGS (LOSS) OF SUBSIDIARIES, NET
   
12,007
     
(4,736
)
NET INCOME (LOSS)
 
$
12,169
   
$
(386
)

(1)
Under the terms of a tax-sharing agreement, income tax provisions for the subsidiary companies are computed on a separate company basis. Accordingly, the Company’s income tax benefit results from the utilization of the Parent’s separate return loss to reduce the consolidated taxable income of the Company.

See accompanying report of independent registered public accounting firm.

Schedule II
Page 3 of 3

CONDENSED FINANCIAL INFORMATION OF REGISTRANT
ATLANTIC AMERICAN CORPORATION
(Parent Company Only)

STATEMENTS OF CASH FLOWS

   
Year Ended December 31,
 
   
2020
   
2019
 
   
(In thousands)
 
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net Income (loss)
 
$
12,169
   
$
(386
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
               
Realized investment gains, net
   
     
(1,120
)
Unrealized losses  (gains) on equity securities, net
   
191
     
(2,976
)
Depreciation and amortization
   
594
     
552
 
Compensation expense related to share awards
   
437
     
353
 
Distributions received from equity method investees
   
     
51
 
Equity in undistributed (earnings) loss of subsidiaries, net
   
(12,007
)
   
4,736
 
Decrease in intercompany taxes
   
622
     
551
 
Deferred income tax benefit
   
(2,446
)
   
(913
)
Increase in accounts payable and accrued expenses
   
121
     
2,360
 
Other, net
   
917
     
(2,314
)
Net cash provided by operating activities
   
598
     
894
 
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Proceeds from investments sold, called or matured
   
     
3,574
 
Investments purchased
   
     
(1,060
)
Capital contribution to subsidiaries
   
     
(3,500
)
Additions to property and equipment
   
(95
)
   
(44
)
Net cash used in investing activities
   
(95
)
   
(1,030
)
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Payment of dividends on Series D preferred stock
   
(399
)
   
(399
)
Payment of dividends on common stock
   
     
(403
)
Proceeds from shares issued under stock plans
   
9
     
27
 
Treasury stock acquired — share repurchase authorization
   
     
(71
)
Treasury stock acquired — net employee share-based compensation
   
(91
)
   
(92
)
Net cash used in financing activities
   
(481
)
   
(938
)
                 
Net increase (decrease) in cash
   
22
     
(1,074
)
Cash and cash equivalents at beginning of year
   
2,068
     
3,142
 
Cash and cash equivalents at end of year
 
$
2,090
   
$
2,068
 
                 
Supplemental disclosure:
               
Cash paid for interest
 
$
1,665
   
$
2,155
 
Cash paid for income taxes
 
$
3,883
   
$
1,662
 
Intercompany tax settlement from subsidiaries
 
$
1,798
   
$
3,335
 

See accompanying report of independent registered public accounting firm.

Schedule III
Page 1 of 2

ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
SUPPLEMENTARY INSURANCE INFORMATION

Segment
 
Deferred
Acquisition
Costs
   
Future Policy
Benefits,
Losses,
Claims and
Loss
Reserves
   
Unearned
Premiums
   
Other Policy
Claims and
Benefits
Payable
 
   
(In thousands)
 
December 31, 2020:
                       
Bankers Fidelity
 
$
37,312
   
$
115,136
   
$
4,199
   
$
1,526
 
American Southern
   
2,299
     
54,883
     
22,932
     
 
   
$
39,611
   
$
170,019
(1) 
 
$
27,131
   
$
1,526
 
                                 
December 31, 2019:
                               
Bankers Fidelity
 
$
36,882
   
$
121,657
   
$
4,606
   
$
1,933
 
American Southern
   
1,979
     
52,281
     
21,429
     
 
   
$
38,861
   
$
173,938
(2) 
 
$
26,035
   
$
1,933
 

(1)
Includes future policy benefits of $90,872 and losses and claims of $79,147.
(2)
Includes future policy benefits of $92,490 and losses and claims of $81,448.

See accompanying report of independent registered public accounting firm.

Schedule III
Page 2 of 2

ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
SUPPLEMENTARY INSURANCE INFORMATION

Segment
 
Premium
Revenue
   
Net
Investment
Income
   
Benefits,
Claims,
Losses and
Settlement
Expenses
   
Amortization
of Deferred
Acquisition
Costs
   
Other
Operating
Expenses
   
Casualty
Premiums
Written
 
   
(In thousands)
       
December 31, 2020:
                                   
Bankers Fidelity
 
$
121,167
   
$
4,971
   
$
80,537
   
$
9,803
   
$
24,374
   
$
 
American Southern
   
62,372
     
3,586
     
39,339
     
9,590
     
9,814
     
64,366
 
Corporate & other
   
     
(813
)
   
     
     
6,388
     
 
   
$
183,539
   
$
7,744
   
$
119,876
   
$
19,393
   
$
40,576
   
$
64,366
 
                                                 
December 31, 2019:
                                               
Bankers Fidelity
 
$
123,245
   
$
5,317
   
$
99,684
   
$
8,459
   
$
27,114
   
$
 
American Southern
   
58,680
     
3,689
     
39,541
     
8,829
     
8,303
     
60,328
 
Corporate & other
   
     
(27
)
   
     
     
6,656
     
 
   
$
181,925
   
$
8,979
   
$
139,225
   
$
17,288
   
$
42,073
   
$
60,328
 

See accompanying report of independent registered public accounting firm.

Schedule IV

ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
REINSURANCE INFORMATION

   
Direct
Amount
   
Ceded to
Other
Companies
   
Assumed
From Other
Companies
   
Net
Amounts
   
Percentage
of Amount
Assumed
to Net
 
   
(Dollars in thousands)
 
Year ended December 31, 2020:
                             
Life insurance in force
 
$
294,392
   
$
(11,032
)
 
$
   
$
283,360
       
                                       
Premiums —
                                     
Bankers Fidelity
 
$
193,082
   
$
(71,924
)
 
$
9
   
$
121,167
     
0.0
%
American Southern
   
45,127
     
(5,890
)
   
23,135
     
62,372
     
37.1
%
Total premiums
 
$
238,209
   
$
(77,814
)
 
$
23,144
   
$
183,539
     
12.6
%
                                         
Year ended December 31, 2019:
                                       
Life insurance in force
 
$
257,731
   
$
(11,449
)
 
$
   
$
246,282
         
                                         
Premiums —
                                       
Bankers Fidelity
 
$
195,481
   
$
(72,261
)
 
$
25
   
$
123,245
     
0.0
%
American Southern
   
41,880
     
(5,520
)
   
22,320
     
58,680
     
39.6
%
Total premiums
 
$
237,361
   
$
(77,781
)
 
$
22,345
   
$
181,925
     
12.8
%

See accompanying report of independent registered public accounting firm.

Schedule VI
ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL INFORMATION CONCERNING
PROPERTY-CASUALTY INSURANCE OPERATIONS

                                 
Claims and Claim
Adjustment
Expenses Incurred
Related To
                   
Year Ended
 
Deferred
Policy
Acquisition
Costs
   
Reserves
   
Unearned
Premiums
   
Earned
Premiums
   
Net
Investment
Income
   
Current
Year
   
Prior
Years
   
Amortization
of Deferred
Acquisition
Costs
   
Paid Claims
and Claim
Adjustment
Expenses
   
Premiums
Written
 
   
(In thousands)
 
December 31, 2020
 
$
2,299
   
$
54,883
   
$
22,932
   
$
62,372
   
$
3,586
   
$
39,859
   
$
(520
)
 
$
9,590
   
$
37,645
   
$
64,366
 
                                                                                 
December 31, 2019
 
$
1,979
   
$
52,281
   
$
21,429
   
$
58,680
   
$
3,689
   
$
40,361
   
$
(820
)
 
$
8,829
   
$
37,905
   
$
60,328
 

See accompanying report of independent registered public accounting firm.


64